[
  {
    "chunk_id": 0,
    "text": "Review Nutritional Status Evaluation and Intervention in Chronic Kidney Disease Patients: Practical Approach DonghyukKang, SojungYoun, JiWonMinandEunJeongKo DivisionofNephrology, DepartmentofInternalMedicine, BucheonSt. MarysHospital, CollegeofMedicine, TheCatholicUniversityofKorea, 327, Sosa-ro, Bucheon-si14647, Gyeonggi-do, RepublicofKorea; mc_donghanmail. net(D. potassium. ); sjddestargmail. com(S. Y. ); blueberi12gmail. com(J. W. M. ) Correspondence: neat0505gmail. com; Tel. /Fax: 82-32-340-7161 Abstract Malnutritionisacommonandseriouscomplicationinpatientswithchronickidneydisease (chronic kidney disease), significantly impacting morbidity, mortality, and health-related quality of life. Recognizingthecloseassociationbetweennutritionalstatusandclinicaloutcomes, recentclinicalpracticeguidelineshaveemphasizedproactivenutritionalassessmentand individualizedinterventionaskeycomponentsofCKDmanagement. Accuratenutritional assessmentremainschallenginginCKDpatientsduetofluidshifts, alteredbodycomposition, andlaboratoryvariability. Whilevariousnutritionalassessmenttoolsareavailable, theirinterpretationrequirescarefulconsiderationduetoeachtoolscharacteristicsand patientsCKDstage. NutritionalinterventionsmustbetailoredtothepatientsCKDstage, dialysisstatus, andcomorbidityprofile. Strategiesincludeindividualizeddietarycounseling and oral nutritional supplements. Also, patient education and multidisciplinary collaborationparticularlyinvolvingnephrologistsandrenaldietitiansareessentialto improving adherence and long-term outcomes. This review focuses on evaluating the nutritionalstatusandinterventionofCKDpatients, highlightingkeyaspectsbasedonthe latestliteratureandclinicalguidelines. Keywords: chronickidneydisease; malnutrition AcademicEditor: CarloM. Pesce Received: 25July2025 1. Introduction Revised: 2October2025 Accepted: 13October2025 Malnutritionisverycommoninthechronickidneydisease(chronic kidney disease)population1. This Published: 17October2025 isbecausepatientswithCKDoftenexperiencereducedappetiteduetouremia, chronic Citation: Kang, D. ; Youn, S. ; Min, inflammation, andmetabolicabnormalities, anditisdifficultforthemtomaintainabalJ. W. ; Ko, E. J. NutritionalStatus anceddietduetodietaryrestrictionsuchaslimitationsonprotein, Potassium, phosphorus EvaluationandInterventionin andsodiumintake. Moreover, proteinbreakdownisincreasedwhileproteinsynthesisis ChronicKidneyDiseasePatients: decreasedintheCKDpopulation2, 3. Andvariousmetabolicchangessuchasinsulin PracticalApproach. Nutrients2025, 17, resistanceandheightenedinflammatoryresponsesfurtherworsennutritionalstatus4. In 3264. 10. 3390/nu17203264 addition, dialysispatientsmayloseproteinandwater-solublevitaminsduringthedialysis process. Furthermore, comorbidconditionssuchasdiabetesandheartfailure, alongwith Copyright: 2025bytheauthors. themedicationsusedtomanagethem, canalsonegativelyaffectnutritionalstatus57. LicenseeMDPI, Basel, Switzerland. Thisarticleisanopenaccessarticle NutritionalstatusaffectstheprogressionofCKD, andconversely, theprogressionof distributedunderthetermsand CKDalsoimpactsnutritionalstatus. Moreover, nutritionalstatusplaysacriticalroleinthe conditionsoftheCreativeCommons clinicaloutcomesofCKDpatients, includingmortalityandhospitalizationrates. Therefore, Attribution(CCBY)license propermanagementofnutritionisessential8. ( licenses/by/4. 0/). Nutrients2025, 17, 3264 Nutrients2025, 17, 3264 2of26 Inthisreview, weoutlineapracticaloverviewofnutritionalassessmentandintervention strategies for patients with chronic kidney disease, grounded in the latest evidence and clinical guidelines. 2. ComplexRelationshipBetweenMalnutritionandClinicalOutcomes inCKDPatients Malnutrition is a prevalent and critical concern in patients with chronic kidney disease, intricately linked to disease progression and adverse clinical outcomes 9. As Kidney function declines, patients often experience a combination of factorssuch as reduced appetite, dietaryrestrictions, inflammation, metabolicacidosis, andgastrointestinalsymptomsthat contributetoinadequatenutritionalintakeandnutrientloss10. Thiscomplexinterplay results in a High risk of Protein-energy wasting (protein-energy wasting), a condition marked by the loss ofbodyproteinandenergyreserves, whichsignificantlycompromisesimmunefunction, physicalperformance, andoverallqualityoflife1113. TheconsequencesofmalnutritioninCKDareprofoundandmultifaceted. Numerous studieshaveshownthemalnourishedCKDpatients, particularlythoseundergoingdialysis, faceincreasedratesofhospitalization, longerrecoverytimes, higherinfectionrisk, and higher all-cause mortality 14. Moreover, malnutrition contributes to muscle wasting andfrailty, bothofwhicharestrongpredictorsofpoorclinicaloutcomes, includingfalls, disability, andcardiovascularevents. Inflammation, commonlypresentinCKD, further exacerbatesmalnutritionbyincreasingcatabolismandimpairingappetite, creatingavicious cycleoftenreferredtoasthemalnutrition-inflammationcomplexsyndrome(MICS)1518. Addressing malnutrition in chronic kidney disease requires a comprehensive and multidisciplinary approach, identifyingpatientsatriskandguidingtimelyinterventions. However, effective managementmustalsoconsiderunderlyingcausessuchasinflammation, fluidimbalance, andpsychosocialfactors. Giventhestrongassociationbetweennutritionalstatusandclinicaloutcomes, earlyrecognitionandtargetednutritionalstrategiesareessentialcomponents ofoptimalCKDcare. 3. NutritionalAssessmentTool The2020KidneydiseaseOutcomesQualityInitiative(Kidney Disease Outcomes Quality Initiative)guidelinesrecommend assessingthenutritionalstatusofCKDpatientsatleasttwiceyearafterstage3, usingsix keycomponents: anthropometricmeasurements, laboratorymeasurements, functionaltests suchashandgripstrength, measurementofenergyrequirements, compositenutritional indices, andassessmentofproteinandcalorieintake19. However, thereisinsufficient evidencetorecommendonescreeningtooloveranother20. Thecommonlyusedtoolsfor assessingnutritionalstatusinpatientswithCKDandtheircharacteristicsaresummarized inTable12022. Nutrients2025, 17, 3264 3of26 Table1. SummaryofNutritionalAssessmentToolsinCKDPatients. AssessmentTool DialysisPatients Non-DialysisCKDPatients Strengths Limitation ClinicalApplication - Affectedbyfluidshifts - Non-invasive - Affectedbyhydration duringandafterdialysis - Earlydetectionofmuscle - Fastandreproducible status - Monitoringovertime - Nodifferentiation BIA betweenhydrationand wasting - Detectsearly - Timingdependencyin - Supportsdiagnosisof - LessstudiedinearlyCKD malnutritionandmuscle Dialysis PEWandsarcopenia musclemassin loss - Limitedaccessandcost: overhydratedpatients. - EarlydetectionofPEW - Subjective; inter-rater - Confoundedbyfluid - CorrelateswitheGFR variability overload, especiallyin - Correlateswithmorbidity - Suitableforroutineuse declineandinflammation - Maymissearly/mild SGA PDpatients. markers andmortality; malnutrition andmonitoring - Doesnotdirectlyquantify - Easy, Low-cost nutritionaltrends - Lessvalidatedinearly - Fluidoverloadcanaffect musclemassorintake. CKDstages. accuracy - Includeslabmarkersand - Strongprognosticvalue - AssociatedwitheGFR - Time-consuming comorbidities - Influencedby declineandriskofPEW - Includessubjectiveitems - Betterpredictionof - Fortrackingchangesover MIS inflammationand overtime outcomesvs. SGA - Maybeinfluencedby time comorbidities, notjust - LessvalidatedinCKD inflammationmorethan - Longitudinally nutrition. stages13. malnutrition responsive - Easytomeasureand - Cannotdistinguishfatvs. - Measurepost-dialysisdry monitor musclemass - Screenfor - Reliablebutadjustcutoffs body mass index weight (e. g. , 23kg/m2risk) - Cansignalundernutrition - Affectedbyfluidstatus malnutrition/obesity - Watchforfluidoverload (e. g. , body mass index18) - Maymasksarcopenic - Monitorrendsmonthly - Associatedwithoutcomes obesity - Reflectsmusclefunction - Influencedby - Usenon-fistulaarm - Earlysarcopenia andproteinreserves comorbidities(e. g. , - Monitorinflammation - 27kgmen, 16kg detection HGS womenindicates - 20kgmen, 12kg - Correlateswithoutcomes neuropathy) andnutritionalstatus andPEW - Standardizationof monthly sarcopenia womenrisk - Inexpensiveandquick measurementisessential Nutrients2025, 17, 3264 4of26 Table1. Cont. AssessmentTool DialysisPatients Non-DialysisCKDPatients Strengths Limitation ClinicalApplication - Associatedwithmortality - Affectedbyinflammation, - Notrecommendedas SerumAlbu- - 3. 8g/dLrisk - 3.",
    "word_count": 572,
    "char_count": 8465,
    "sentence_count": 65,
    "metadata": {
      "source_file": "e554aa91d426eee7edf579315638edf64d3f.pdf",
      "extraction_date": "2025-12-31T14:48:14.772187",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "chronic kidney disease",
        "CKD",
        "dialysis",
        "kidney function",
        "renal",
        "nephrology"
      ],
      "chunk_index": 0,
      "total_chunks": 11,
      "position": "1/11",
      "section": "Review Nutritional Status Evaluation and Intervention in Chronic Kidney Disease Patients:",
      "content_type": "dietary",
      "content_type_confidence": 13,
      "medical_entities": [
        "chronic kidney disease",
        "kidney function",
        "potassium",
        "phosphorus",
        "nutrition",
        "malnutrition",
        "supplements",
        "dialysis",
        "neuropathy",
        "patient education"
      ],
      "entity_count": 10
    }
  },
  {
    "chunk_id": 1,
    "text": "Cont. AssessmentTool DialysisPatients Non-DialysisCKDPatients Strengths Limitation ClinicalApplication - Associatedwithmortality - Affectedbyinflammation, - Notrecommendedas SerumAlbu- - 3. 8g/dLrisk - 3. 5g/dLrisk risk liverfunction, fluidstatus standalone min/Prealbumin - Considerinflammation - InterpretwithCRP - Prealbuminresponds - Notspecificfor - Useassupplementary fastertointerventions malnutrition indicator - Estimatesdietaryprotein intake - Complextocalculate - Estimatedviaurineurea - Reflect - Guideproteinintake - Target≥1. 0g/kg/day - Affectedbyresidualrenal nPCR - 0. 5indicatesPEW - 0. 81. 0g/kg/day nutrition-inflammation function, catabolism, - Assessintervention recommended balance efficacyquarterly inflammation - Trackschange post-intervention - Combinesphenotypic - Useweightlossand - AccuracyvariableinCKD etiologiccriteria - Screenat-riskpatients GLIMcriteria - UseDXAformusclemass intakedata - Promotesglobal - Lowconcordancewith - Every36months - Inflammationimportant SGAinsomestudies standardization BIA, bioelectricalimpedanceanalysis; chronic kidney disease, chronickidneydisease; HGS, handgripstrength; GLIM, globalleadershipinitiativeonmalnutritionMIS, malnutritioninflammationscore; protein-energy wasting, Protein-energywasting; peritonealdialysis; SGA, subjectiveglobalassessment. Nutrients2025, 17, 3264 5of26 (1) Toassessbodycomposition: Bioeletricalimpedance Bioelectrical Impedance Analysis (BIA) is a non-invasive, rapid, and reproducible method widely used to assess body compositionincluding lean mass, fat mass, and hydration statusin chronic kidney disease patients. Its clinical value lies in detecting protein-energy wasting and fluid imbalances, whicharecriticaldeterminantsofmorbidityandmortalityinthispopulation. The utility and interpretation of BIA vary according to chronic kidney disease stage and Dialysis status. In early chronic kidney disease stages 12, BIA can identify subtle decreases in phase angle (PA)a raw parameterreflectingcellmembraneintegrityandhydrationwherevaluesbelow6 are associated with worse outcomes 23. As chronic kidney disease progresses to stages 34, fluid overload becomes more prevalent, necessitating cautious interpretation of BIA data; a PA below 5. 0 andleantissueindexbelowthe10thpercentileforageandsexindicatemalnutrition andmusclewasting19. Non-dialysisstage5CKDpatientsposefurtherchallengesdue to persistent volume overload and inflammation, making repeated BIA measurements essentialtotracktrendsratherthanrelyingonsingleabsolutevalues. Indialysispatients, BIAismostaccuratewhenperformed30to60minpost-dialysistoavoidoverestimation ofleanmasscausedbyexcessextracellularfluid, withdryweightestimationstypically within1. 5kgofclinicalassessments24. Inpatientswithlimbamputations, standardwhole-bodyBIAprotocolsareunreliable due to altered body geometry and the loss of conductive tissue pathways, which can underestimate lean mass by 1015% 25. Thus, segmental BIA and the application of population-specificcorrectionfactorsapproximately5. 9%forbelow-kneeand10. 4%for above-kneeamputationsarerecommendedtoimproveaccuracy19, 26. Foramputees undergoingdialysis, BIAmeasurementsshouldbeperformedinaeuvolemicstate, preferablypost-Dialysis, tominimizetheconfoundingeffectsoffluidshifts. Serialassessments ratherthansingletimepointsprovidebetterclinicalinsightintonutritionalstatus. Due tothesecomplexities, BIAdatainamputeesshouldalwaysbeinterpretedalongsideother nutritionalassessmentssuchashandgripstrength, SubjectiveGlobalAssessment(SGA), andbiochemicalmarkerstoaccuratelydiagnoseprotein-energywastingandguidetailored interventions24. Overall, BIA remains a valuable adjunct in the nutritional management of chronic kidney disease patients, withcarefulattentiontoCKDstage, dialysistiming, andpatient-specificfactors likeamputationensuringoptimalclinicalapplication. (2) SubjectiveGlobalAssessment SubjectiveGlobalAssessment(SGA)isavalidatedclinicaltoolthatintegratespatient historyandphysicalexaminationtoclassifynutritionalstatusaswell-nourished(A), moderately malnourished (B), or severely malnourished (C) by evaluating weight changes, dietaryintake, gastrointestinalsymptoms, functionalcapacity, andphysicalsignsofmuscle andfatloss27. Itssimplicity, cost-effectiveness, andbedsideapplicabilitymakeithighly valuableinCKDpopulations, wheremalnutritionprevalencerangesfromapproximately 20%inearlystagestoover40%indialysis-dependentpatients19. InearlyCKDstages12, SGAdetectssubtlenutritionaldisturbancesthatmaynotyet bereflectedinbiochemicaloranthropometricdata, suchasweightlossexceeding5%over 36monthsordecreasedfoodintakebelow75%oftheusualformorethanaweek, enabling earlynutritionalintervention20. Instages34, whereuremicsymptomslikeanorexia, nausea, andfatiguebecomemoreprevalent, moderatetosevereSGAscorescorrelatewitha two-tothreefoldincreaseinhospitalizationandmortalityrisk, withweightlossexceeding 10%oversixmonthsmarkingapoorprognosis28. Fornon-dialysisstage5patients, fluid retention complicates assessment, necessitating careful interpretation of physical signs Nutrients2025, 17, 3264 6of26 such as temporal muscle wasting or subcutaneous fat loss to avoid underestimation of malnutrition. Indialysispatients, wherecatabolicprocessesandinflammationacceleratenutritional decline, SGAisrecommendedeverythreemonthstomonitorstatus. Scoresabove6on the7-pointSGAscaleassociatewithincreasedmortalityrisk22. ConductingSGAson non-dialysisorpost-dialysisdaysminimizesconfoundingfromfluidoverload. Inspecial populationssuchascancerpatients, SGAcapturessymptomatology(e. g. , anorexia, early satiety)providingsuperiorprognosticvalueoverbodymassindex(body mass index)alone29. StrengthsofSGAincludeitspracticality, multidimensionalassessmentofnutrition, and validation across chronic kidney disease stages, allowing for repeated, Low-cost bedside screening. Limitationsstemfromitssubjectivenature, potentialinterobservervariability, andreduced precisioncomparedtoquantitativetools. However, structuredtrainingandstandardized scoringsystemsenhancereproducibilityandclinicalutility, makingSGAacornerstoneof nutritionalevaluationinCKDwhencombinedwithobjectivemeasures30. (3) MalnutritionInflammationScore Malnutrition-InflammationScore(MIS)isacomprehensivetooldevelopedtoassess bothnutritionalandinflammatorystatus, particularlyindialysispatientswithCKD. BuildingontheSGA, MISincorporatesadditionalobjectiveparametersincludingserumalbumin, totaliron-bindingcapacity(TIBC), body mass index, comorbidities, andfunctionalstatus, resultingin a multidimensional evaluation. The total score ranges from 0 to 30, with higher scores indicatingmoreseveremalnutritionandinflammation28. MIS is a strong predictor of adverse clinical outcomes such as hospitalization and mortality, especiallyindialysispatientswhereinflammationisprevalentin3050%ofcases andexacerbatesprotein-energywasting19. Scoresabove78correlatewithatwo-to threefoldincreasedriskofmortalityandmorbiditywithin12months28. Thisprognostic powersurpassesthatofSGAorserumalbuminalone, makingMISparticularlyvaluable forguidingnutritionalandanti-inflammatoryinterventionsinthishigh-riskgroup. In non-Dialysis chronic kidney disease patients, especially in advanced stages 4 and 5, MIS aids in differentiatingmalnutritiondrivenbyinflammationfromothercauses, althoughitsroutine use is limited by the need for frequent laboratory data 19. An MIS above 6 in these patientssignalstheneedforclosenutritionalmonitoringandintervention. MIScorrelateswellwithobjectivemarkerssuchashandgripstrengthandleanbody mass, allowing for cross-validation of nutritional status 31. However, its complexity, timerequirements, anddependenceonlaboratorytestsmakeitlessfeasibleinresourcelimitedsettings. Furthermore, despitestructuredtraining, somesubjectivityandinter-rater variabilitypersist20, 28. Despiteitsadvantages, theMISismoretime-consumingandcomplextoadminister compared to simpler tools such as the SGA. It requires laboratory values and trained personnelforaccurateevaluation, whichlimitsitspracticalityandwidespreaduseoutside specializeddialysiscenters. Additionally, somecomponentsoftheMISstillrelyonclinical judgment, introducingpotentialinter-ratervariabilityandsubjectivityintheassessment. Regularreassessmenteverythreemonthsisrecommendedtomonitordiseaseprogressionandtreatmentresponse20. (4) BodyMassIndex BodyMassIndex(body mass index)isasimple, widelyused, andnon-invasivetoolforassessing nutritionalstatusinpatientswithCKD. Itestimatesbodyfatbasedonweightandheight, servingasaninitialscreeningparameterforundernutritionorobesity32, 33. InCKDpopulations, particularlythoseondialysis, alowBMIhasbeenlinkedtoincreasedmorbidity andmortality, makingitavaluableprognosticindicator34. Nutrients2025, 17, 3264 7of26 However, BMIhasnotablelimitationsinthiscontext. Itdoesnotdifferentiatebetween fatmassandleanbodymass, nordoesitaccountforfluidoverload, whichiscommonin CKDandcanmasktruebodycomposition35. Consequently, BMImayunderestimateor overestimatenutritionalstatusinpatientswithedemaormusclewasting36. Furthermore, BMIdoesnotcapturedynamicnutritionalchangesovertimeandlacksinformationon micronutrientstatusorinflammation. Despitetheselimitations, BMIremainsaconvenient andaccessibleinitialscreeningtoolwhencombinedwithclinical, biochemical, andfunctionalassessmentstoprovideamorecomprehensiveevaluationofnutritionalstatusin CKDpatients. Indialysispatients, fluidshiftsandoverloadcanconfoundBMIinterpretation, often causingoverestimationofadiposity19. BMIshouldideallybemeasuredpost-dialysisor atdryweighttoimproveaccuracy.",
    "word_count": 599,
    "char_count": 9549,
    "sentence_count": 62,
    "metadata": {
      "source_file": "e554aa91d426eee7edf579315638edf64d3f.pdf",
      "extraction_date": "2025-12-31T14:48:14.772187",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "chronic kidney disease",
        "CKD",
        "dialysis",
        "kidney function",
        "renal",
        "nephrology"
      ],
      "chunk_index": 1,
      "total_chunks": 11,
      "position": "2/11",
      "content_type": "dietary",
      "content_type_confidence": 7,
      "medical_entities": [
        "chronic kidney disease",
        "nutrition",
        "malnutrition",
        "dialysis",
        "fluid overload",
        "screening"
      ],
      "entity_count": 6
    }
  },
  {
    "chunk_id": 2,
    "text": "Consequently, BMImayunderestimateor overestimatenutritionalstatusinpatientswithedemaormusclewasting36. Furthermore, BMIdoesnotcapturedynamicnutritionalchangesovertimeandlacksinformationon micronutrientstatusorinflammation. Despitetheselimitations, BMIremainsaconvenient andaccessibleinitialscreeningtoolwhencombinedwithclinical, biochemical, andfunctionalassessmentstoprovideamorecomprehensiveevaluationofnutritionalstatusin CKDpatients. Indialysispatients, fluidshiftsandoverloadcanconfoundBMIinterpretation, often causingoverestimationofadiposity19. BMIshouldideallybemeasuredpost-dialysisor atdryweighttoimproveaccuracy. Notably, dialysispatientsexhibitanobesityparadox, wherehigherBMI(30kg/m2)associateswithbettersurvivalcomparedtounderweight individuals(body mass index18. 5kg/m2), whofaceatwofoldincreasedmortalityrisk37. Because BMIalonecannotdistinguishmusclefromfatmass, complementarymethodslikeBIAor handgripstrength(HGS)arerecommended. Fornon-dialysisCKDpatients, BMIinterpretationismorereliableduetolesspronouncedfluidoverloadbutstillrequirescaution, especiallyinadvancedstages4520. A body mass index below 23 kg/m2 is associated with higher risk of progression to end-stage kidney disease and mortality, particularly when combined with unintentional weight loss exceeding5%oversixmonths. Conversely, obesity(body mass index≥30kg/m2)contributestoCKD progressionthroughmetaboliccomplicationssuchasinsulinresistanceandinflammation. Therefore, BMIcutoffsinCKDpopulationsmaydifferfromgeneralguidelinesandshould beinterpretedalongsideothernutritionalmarkersandclinicalcontext. Whilelimitedbyitsinabilitytodistinguishbetweenfat, muscle, andfluid, BMIremains apractical, inexpensive, andwidelyavailabletoolsuitableforlongitudinalmonitoring. Regular body mass index assessment every 13 months helps detect early nutritional deterioration orexcessiveweightgain, enablingtimelyinterventionswhenusedinconjunctionwith functionalandbiochemicalevaluations. (5) Handgripstrength HandgripStrength(HGS)isasimple, non-invasive, andcost-effectivetoolforassessing musclestrengthandnutritionalstatusinpatientswithCKD38, 39. Asadirectmeasureof musclefunction, HGSisparticularlyvaluableinidentifyingsarcopeniaandmalnutrition, conditions commonly seen in chronic kidney disease 40. It correlates strongly with clinical outcomes includinghospitalization, morbidity, andmortality, andcandetectearlymusclefunction declinenotapparentthroughanthropometricorbiochemicalmeasures17. Indialysispatients, HGSistypicallymeasuredonthenon-fistulaarmbeforedialysis toavoidtheeffectsoffatigueandfluidshifts19. Cutoffvaluesbelow27kgformenand 16kgforwomenarewidelyacceptedtodiagnoseclinicallysignificantmuscleweakness andsarcopenia24. Patientsbelowthesethresholdshavea1. 5-to3-foldincreasedriskof hospitalizationandmortalitywithin12months, independentofBMIorserumalbumin. HGSalsorespondstonutritionalandexerciseinterventions, withimprovementsof23kg commonlyobservedaftertargetedtherapies19. In non-Dialysis chronic kidney disease patients, Low HGS predicts faster progression to end-stage Kidney disease (end-stage renal disease) and increased mortality, often preceding detectable changes in body composition. Additionally, HGS is useful in monitoring frailty, especially in elderlyCKDpopulationswherefrailtyprevalencecanreach50%, aidinginpersonalized rehabilitation24. LimitationsofHGSincludeitsdependencyonpatienteffort, influencebyhanddominance, and comorbidities such as arthritis or neuropathy, which may affect reliability. Nutrients2025, 17, 3264 8of26 Standardizedprotocolsrecommendtakingthehighestofthreeattemptsandadjustingfor ageandsexnormstoimprovereproducibility39. Despitetheselimitations, HGSremains avital, objectivebiomarkerthatcomplementsothernutritionalandfunctionalassessments inCKD. (6) Serumalbumin/pre-albumin Serumalbuminandpre-albuminarecommonlyusedbiochemicalmarkersinassessingnutritionalstatusinpatientswithCKD, duetotheirassociationwithprotein-energy wasting and clinical outcomes 31. Serum albumin, with a longer half-life (20 days), reflectschronicnutritionalstatusandinflammation, consistentlypredictingmorbidityand mortalityinbothdialysisandnon-dialysisCKDpopulations17. Levelsbelow3. 8g/dL indialysispatientscorrelatewithincreasedhospitalizationandmortalityrisk, witheach 0. 1g/dLdecreaselinkedtoa1015%higherriskofdeath28. Pre-albumin(transthyretin), withashorterhalf-life(2days), ismoresensitivetoacute nutritionalchangesandcanbeusedtomonitortheeffectivenessofnutritionalinterventions over shorter periods. Values below 30 milligrams per deciliter in Dialysis patients are associated with malnutritionandworseoutcomes. Pre-albuminislessaffectedbyhydrationstatusbut remainssensitivetoinflammation, limitingitsspecificity21, 22. Both markers, however, have important limitations. They are influenced by nonnutritionalfactorssuchasinflammation, hydrationstatus, liverfunction, andinfections, whichareprevalentinCKDandcomplicateinterpretation. Forexample, hypoalbuminemia oftenreflectssystemicinflammationratherthanpuremalnutrition. Theirlevelsmayalso remain normal despite significant muscle wasting or inadequate dietary intake. Therefore, serumalbuminandpre-albuminshouldbeinterpretedinconjunctionwithclinical evaluation, dietaryhistory, inflammatorymarkerslikeC-reactiveprotein(CRP), andother nutritionalassessmentstoensureaccuratediagnosis31. Innon-dialysisCKD, hypoalbuminemia(3. 5g/dL)predictsfasterprogressionto end-stagekidneydiseaseandincreasedcardiovascularmortality, independentofeGFR. Serialmeasurementshelpdetectclinicallysignificantdeclines(0. 2g/dLover3months) indicatingworseningnutritionalorinflammatorystatus. Special populations, such as frail elderly or cancer-associated chronic kidney disease patients, often present with hypoalbuminemia driven by combined inflammation, Protein catabolism, and reduced intake, correlating with poor prognosis. Despite their limitations, serum albuminandpre-albuminremainvaluableprognosticmarkersandcomponentsofmultifactorialnutritionalassessmentinCKD, withrecommendedmonitoringintervalsevery 13months20. (7) Normalizedproteincatabolicrate Normalized Protein catabolic rate (nPCR) is a biochemical tool primarily used in dialysispatientstoestimatedailyproteinintakebycalculatingureanitrogengeneration normalizedtobodyweight(g/kg/day), servingasanindirectmarkerofdietaryprotein consumptionandnutritionalstatus19. AtargetnPCR≥1. 0g/kg/dayisrecommended indialysispatientstomaintainnitrogenbalance, whilevaluesbelow0. 8g/kg/dayindicate insufficientproteinintakeandincreasedriskofPEW, correlatingwithhighermorbidity andmortality. nPCRisderivedfrompre-andpost-dialysisbloodureanitrogen(blood urea nitrogen)measurements, Dialysis adequacy (dialysis adequacy measure), and patient weight, making it highly useful for monitoring and guiding individualized nutritional interventions over time. In peritoneal Dialysis, adjustmentsforcontinuousdialysateclearanceandresidualrenalfunctionarenecessary foraccuratecalculation. Nutrients2025, 17, 3264 9of26 However, nPCRassumessteady-statemetabolicanddialysisconditions, whichmay notapplyinacutelyillorunstablepatients, potentiallylimitingreliability. Additionally, nPCRcanbeconfoundedbynon-nutritionalfactorssuchasinflammation, catabolicstress, andresidualrenalfunction, possiblyleadingtoover-orunderestimationoftrueprotein intake. Therefore, it should be interpreted alongside inflammatory markers such as Creactiveprotein(CRP)todistinguishmalnutritionfromhypercatabolicstates21. In non-Dialysis chronic kidney disease patients, nPCR is less commonly used due to the absence of Dialysis-relatedmeasurements, but24hurineureanitrogencanestimateproteinintake, withtargetsaround0. 81. 0g/kg/daydependingonCKDstageandcomorbidities. Low nPCR (0. 8 g/kg/day) in advanced chronic kidney disease stages signals inadequate Protein intake and warrantsnutritionalsupport20. Limitations of nPCR include dependence on accurate blood urea nitrogen and Dialysis adequacy data, inabilitytoassessenergyintakeormicronutrientstatus, andpotentialinaccuracies duringnon-steady-stateconditions. Despitetheseconstraints, nPCRremainsavaluable, objective marker for assessing Protein intake and guiding nutritional management in Dialysis-dependentCKDpatients, withrecommendedmonitoringevery13months19. (8) GLIMcriteria The Global Leadership Initiative on Malnutrition (GLIM) criteria diagnose malnutritionthroughcombinedphenotypic(weightloss, lowBMI, reducedmusclemass)and etiologicfactors(reducedfoodintake/assimilationandinflammation), requiringatleast onecriterionfromeachcategory. Thisframeworkeffectivelyaddressesthemultifactorial natureofmalnutritioninCKD41 Indialysispatients, malnutritionprevalencebyGLIMcriteriaisapproximately3050%, stronglyassociatedwithincreasedhospitalizationandmortality(Phenotypicthresholds include unintentional weight loss 5% over 6 months, body mass index 20 kg/m2 (70 years) or 22kg/m2 (≥70years), andreducedmusclemassassessedviabioelectricalimpedance analysis(BIA)ordual-energyX-rayabsorptiometry(DXA)). Etiologicfactorsemphasize reducedfoodintake(50%ofenergyneedsfor1week)andinflammation, whichaffects uptohalfofdialysispatients19. Innon-dialysisCKD, GLIMislesscommonlyusedbutremainsapplicable; weightloss andreducedintakeserveasprimaryindicators, withinflammationgainingimportance inadvancedstages35. NutritionalinterventionsguidedbyGLIMhavebeenshownto improveoutcomesandslowprotein-energywasting20. CKDstage-specificconsiderationsinclude: Stages12: Detectionmainlythroughweightloss5%in6monthsandreducedintake (50%energyneedsfor1week), withinflammationplayingalesserrole. Stages34: Inflammationbecomesamoreprominentetiologicfactor; musclemass assessmentusingBIAorhandgripstrengthimprovesearlydetectionofmalnutrition. Stage 5 (non-Dialysis and Dialysis): Frequent inflammation and fluid overload make GLIM particularly valuable, with phenotypic criteria including body mass index cutoffs, weight loss, and muscle mass measurement via BIA or DXA. Assessment every 36 months is recommended. LimitationsofGLIMincludetheneedforvalidatedmusclemassmeasurementtools and the potential subjectivity in estimating reduced food intake, which may restrict its implementationinsomeclinicalsettings. Nutrients2025, 17, 3264 10of26 4.",
    "word_count": 600,
    "char_count": 10224,
    "sentence_count": 73,
    "metadata": {
      "source_file": "e554aa91d426eee7edf579315638edf64d3f.pdf",
      "extraction_date": "2025-12-31T14:48:14.772187",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "chronic kidney disease",
        "CKD",
        "dialysis",
        "kidney function",
        "renal",
        "nephrology"
      ],
      "chunk_index": 2,
      "total_chunks": 11,
      "position": "3/11",
      "content_type": "dietary",
      "content_type_confidence": 6,
      "medical_entities": [
        "chronic kidney disease",
        "end-stage renal disease",
        "urea",
        "blood urea nitrogen",
        "malnutrition",
        "dialysis",
        "peritoneal dialysis",
        "dialysis adequacy",
        "neuropathy",
        "fluid overload"
      ],
      "entity_count": 10
    }
  },
  {
    "chunk_id": 3,
    "text": "LimitationsofGLIMincludetheneedforvalidatedmusclemassmeasurementtools and the potential subjectivity in estimating reduced food intake, which may restrict its implementationinsomeclinicalsettings. Nutrients2025, 17, 3264 10of26 4. NutritionalIntervention (1) Energy(Calorie)Intake Maintainingadequateenergyintakeisacornerstoneinthenutritionalmanagementof CKDtopreventPEW, asyndromecharacterizedbylossofbodyproteinandfatstoresthat significantlyincreasesmorbidity, hospitalization, andmortalityacrossallCKDstages42. KidneyDiseaseImprovingGlobalOutcomes(Kidney Disease: Improving Global Outcomes)2024guidelinesemphasizetailoring energyintaketomeetindividualmetabolicdemands, therebypreventingcatabolismand ensuringthatdietaryproteinsupportsanabolicfunctionssuchastissuerepairandimmune responseratherthanservingasanenergysubstrate20. EnergyrequirementsvaryacrossCKDstagesandaccordingtodialysisstatus, reflectingdifferencesinmetabolicrate, inflammation, andfluidbalance. InearlyCKDstages13, Kidney Disease: Improving Global Outcomes, Kidney Disease Outcomes Quality Initiative, European society of clinical nutrition and metabolism (ESPEN), and InternationalSocietyofRenalNutritionandMetabolism(ISRNM)uniformlyrecommend energyintakeof3035kcal/kgidealbodyweightperday, givenrelativelystablemetabolic conditionsandminimalcatabolicstress. However, adjustmentsshouldbemadebasedon age, physicalactivity, andcomorbidities; olderadultsandsedentarypatientsmayrequire intakeatthelowerendofthisrangetoavoidovernutrition. Instages45CKDwithoutdialysis, energyneedsareslightlymorevariabledueto increasingmetabolicderangementsandoftenchronicfluidoverload. Guidelinessuggest maintaining2535kcal/kg/day, withcarefulmonitoringtobalancetherisksofundernutritionandovernutrition(Table2). In Dialysis populations, metabolic demands and Protein turnover increase due to Dialysis-related inflammation, catabolic stimuli, and loss of amino acids during treatment. Consequently, higherenergyintakeisnecessary. KDIGOandKDOQIrecommend 3040kcal/kgidealbodyweightperdayindialysispatientstocompensateforincreased energyexpenditureandtopreserveleanbodymassandfunctionalstatus. ESPENechoes theserecommendations, emphasizingtheneedforindividualizedassessmentgiventhe heterogeneity of Dialysis patients, while ISRNM stresses the importance of frequent reassessmentstoaccountforfluctuationsinclinicalstatus. Energyprovisionshouldprioritizenutrient-densesourceswithemphasisonhealthy fats (monoand polyunsaturated fatty acids), complex carbohydrates, and fiber, while minimizingsimplesugarsandultra-processedfoodstoreducemetabolicstress. Forpatients unable to meet energy needs through diet alone, oral nutritional supplements (ONS), preferably High in Protein and energy, are recommended to prevent or reverse weight loss and frailty. Increasing meal frequency to five to six small meals or snacks per day, ratherthanthetraditionalthreelargemeals, canimproveoverallintakewithoutcausing gastrointestinal discomfort. Energy-dense foods such as nut butters, avocados, full-fat dairyproducts, andhealthyoils(oliveorcanola)areeffectivestrategiestoenhancecaloric intakeefficiently. Addressingmodifiablefactorsthatimpairappetiteiscriticaltooptimizeenergyintake. Correctionofmetabolicacidosiswithoralbicarbonateimprovesappetiteandmusclepreservation, whilemanagementofchronicinflammation, uremictoxins, anddepressionsupports patientengagementandadherencetonutritionalplans. Psychologicalandpharmacologic interventionsfordepressionfurtherenhanceappetiteanddietarycompliance. Nutrients2025, 17, 3264 11of26 Table2. RecommendedNutrientIntakebyCKDStageandSpecialConditions. MalignancyPatients Nutrients CKDStage13 CKDStage45 DialysisPatients FrailtyCKDPatients withCKD 3040kcal/kg/day 3040kcal/kg/day 3040kcal/kg/day 3545kcal/kg/dayin Energyintake 3035kcal/kg/day 3035kcal/kg/day (adjustedforageand 4045kcal/kg/dayin hypermetabolicstatesor activity) cachexia activemalignancy 0. 8g/kg/day Atleast1. 01. 2g/kg/day Moderaterestrictiontoslow 0. 60. 8g/kg/day Upto1. 5g/kg/day, to 1. 21. 5g/kg/day ProteinIntake 1. 21. 4g/kg/day CKDprogression MonitoredtoavoidPEW preservemusclemassand Avoidexcessiverestriction Butavoidmalnutrition function 2. 3g/day 2. 3g/day Monitorcarefullydueto SodiumIntake 2. 3g/day 2. 3g/day 2. 0g/dayorless Balancedwithsymptom frailty-related controlandpatienttolerance hyponatremiarisk Generallyunrestricteddue Restrictasneededbasedon todialyticremoval Usuallyunrestrictedif 2. 03. 0g/dayifserumK kidneyfunctionand PotassiumIntake Limitto3. 04. 0g/daybased Individualized serumK5. 0mEq/L 5. 0mEq/L chemotherapy-induced onserumKanddialysis electrolytedisturbances adequacy 800mg/dayorless; 8001000mg/day 8001000mg/day 800mg/dayorless 8001000mg/day Phosphorusbindersoften Phosphorusbinders PhosphorusIntake Avoidexcessiveintaketo Restrictionwithriskof Minimizebonecomplications requiredasCKD standard delaymineralbonedisorder proteinmalnutrition andtumorlysissyndrome progresses monitorPTHlevels chronic kidney disease, chronickidneydisease; protein-energy wasting, Protein-energywasting. Nutrients2025, 17, 3264 12of26 Earlyidentificationofnutritionalriskallowsfortimelyinterventions. Renaldietitians shouldprovideindividualizedmealplanningthatprioritizesenergy-dense, nutrient-rich foodstomeetcaloricgoalswhilemaintainingproteinrestriction. Useoforalnutritional supplementstailoredforrenalpatientscanhelpachieveenergytargetswithoutexcessive proteinorelectrolytesAdditionally, counselingshouldemphasizeeducationonappropriate portionsizes, nutrienttiming, andstrategiestoovercomeanorexia, suchassmallfrequent meals and flavor enhancement. Multidisciplinary coordination between nephrologists, dietitians, nurses, andpharmacistsensurescomprehensivemanagementofcomorbidities thatmayimpactnutrition, suchasdiabetesorcardiovasculardisease. (2) ProteinIntake InpatientswithCKD, lowproteindiets(LPDs)arefrequentlyprescribedasatherapeuticstrategytoreducenitrogenouswasteproducts, controluremicsymptoms, andslowthe progressionofrenalfunctiondecline. Thisdietaryinterventionhasshownclinicalbenefits particularlyinthepre-dialysisstages; however, itcarriesasignificantriskofmalnutrition whennotindividualizedorcarefullymonitored21. Proteinisanessentialmacronutrient necessaryforthemaintenanceofmusclemass, tissuerepair, immunefunction, andthesynthesisofvitalenzymesandhormones. GiventhatCKDpatientsoftenexperienceanorexia, systemic inflammation, and increased Protein catabolism, further restriction of Protein intake may precipitate protein-energy wasting, a syndrome characterized by the progressive loss of both proteinandenergystores22. PEWisassociatedwithsarcopenia, compromisedimmune defenses, increasedsusceptibilitytoinfections, diminishedphysicalfunction, andoverall poorerclinicaloutcomes, includinghigherratesofhospitalizationandmortality2325. These risks are further amplified in elderly patients and those with comorbidities such asdiabetesorheartfailure, wherenutritionalrequirementsaremorecomplex26. Additionally, withoutappropriatedietarycounseling, patientsmaymisinterpretLPDsasa mandatetoreduceoverallfoodintake, resultingnotonlyinproteindeficiencybutalso inadequateconsumptionofcaloriesandmicronutrients27. Therefore, althoughLPDscan bebeneficialwhenproperlyprescribed, theymustbeimplementedwithindividualized nutritionalassessments, regularmonitoring, andadequatesupplementationincluding the potential use of keto acid analogsto prevent unintended and harmful nutritional deficiencies28. Amultidisciplinaryapproachinvolvingnephrologists, dietitians, and patientsiscriticaltobalancerenalprotectionwithnutritionaladequacyeffectively. TopreventmalnutritionassociatedwithLPDsinCKDpatients, acarefullybalanced andindividualizednutritionalapproachisessential. Theincorporationofhigh-quality proteinsourcesthatarerichinessentialaminoacidsbutlowinphosphorusandpotassium canoptimizenutrientintakeandminimizecomplicationsrelatedtomineraloverload29. EffectivepreventionofPEWnecessitatesmaintainingproteinintaketargetstailoredtothe patients chronic kidney disease stage or Dialysis modality, while ensuring sufficient daily energy intake, typically 3035 kcal/kg of body weight. For non-Dialysis chronic kidney disease patients, Protein intake isgenerallyrecommendedat0. 60. 8g/kg/day, whereasdialysispatientsrequirehigher proteinintakesofupto1. 01. 2g/kg/daytopreventPEW19, 20. Supplementationwith keto-analogsofessentialaminoacidshasbeendemonstratedtosupportproteinmetabolism withoutincreasingnitrogenouswasteproduction, thusmitigatingmalnutritionriskwhile preservingrenalfunction30. Clinicalstudiesrecommendadailydosageofketo-analog supplementsofapproximately0. 1g/kgofbodyweight, equivalenttoone500mgtablet per5kgofbodyweight, administeredindivideddoseswithmeals31, 32. Forexample, a 70kgpatientwouldrequirearound7gperdayor14tabletsdaily. Thissupplementation maintainsadequateaminoacidavailability, correctsmetabolicimbalances, andmaydelay theinitiationofdialysiswithoutcompromisingnutritionalstatus. EvidencesupportsketoNutrients2025, 17, 3264 13of26 analogtherapyasasafeandeffectivestrategytopreventPEWinpre-dialysisCKDstages, provideditisappropriatelydosedandcarefullymonitored33, 34(Table2). Closemonitoringbyarenaldietitianiscrucialtoensurethatenergyintakeremains adequatetospareproteinfortissuemaintenanceandrepair. Regularnutritionalassessments, includinganthropometricmeasurements, biochemicalmarkers, andclinicalstatus evaluations, enabletimelyadjustmentstodietplans, thuspreventingprogressionofmalnutrition35. Furthermore, patienteducationontheimportanceofdietarycompliance andappropriatefoodchoices, combinedwithmultidisciplinarycollaboration, isvitalfor successfulnutritionalmanagementwhilemaintainingthebenefitsofalowproteindiet. The 2024 Kidney Disease: Improving Global Outcomes clinical practice guideline emphasizes balancing the risks associated with excessive Protein load on the kidneys against the dangers of protein-energy wasting from inadequate intake. For adults with chronic kidney disease stages 3 to 5 who are not on Dialysis, Kidney Disease: Improving Global Outcomes recommendsaproteinintakeofapproximately0. 8g/kgbodyweightperday. Thislevel issufficienttomaintainmusclemasswhilereducingglomerularhyperfiltrationandnitrogenouswastegeneration, bothofwhichcontributetoCKDprogression. Dietshighin Protein(1. 3g/kg/day)arediscouragedforpatientsatriskofkidneyfunctiondecline. In selected, motivatedpatientswithstablemetabolicstatus, KDIGOsupportsconsidering verylow-proteindiets(very Low protein diet)of0. 30. 4g/kg/day, providedtheyaresupplementedwith ketoacidanalogsoressentialaminoacids. Thisinterventionmaydelaytheneedfordialysisandimprovemetabolicoutcomesbutmustonlybeimplementedundercloseclinical anddieteticsupervision.",
    "word_count": 595,
    "char_count": 10718,
    "sentence_count": 84,
    "metadata": {
      "source_file": "e554aa91d426eee7edf579315638edf64d3f.pdf",
      "extraction_date": "2025-12-31T14:48:14.772187",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "chronic kidney disease",
        "CKD",
        "dialysis",
        "kidney function",
        "renal",
        "nephrology"
      ],
      "chunk_index": 3,
      "total_chunks": 11,
      "position": "4/11",
      "content_type": "dietary",
      "content_type_confidence": 15,
      "medical_entities": [
        "chronic kidney disease",
        "nutrition",
        "diet",
        "low protein diet",
        "energy intake",
        "supplements",
        "dialysis",
        "guideline"
      ],
      "entity_count": 8
    }
  },
  {
    "chunk_id": 4,
    "text": "Thislevel issufficienttomaintainmusclemasswhilereducingglomerularhyperfiltrationandnitrogenouswastegeneration, bothofwhichcontributetoCKDprogression. Dietshighin Protein(1. 3g/kg/day)arediscouragedforpatientsatriskofkidneyfunctiondecline. In selected, motivatedpatientswithstablemetabolicstatus, KDIGOsupportsconsidering verylow-proteindiets(very Low protein diet)of0. 30. 4g/kg/day, providedtheyaresupplementedwith ketoacidanalogsoressentialaminoacids. Thisinterventionmaydelaytheneedfordialysisandimprovemetabolicoutcomesbutmustonlybeimplementedundercloseclinical anddieteticsupervision. Suchrestrictiveapproachesarecontraindicatedinmetabolically unstableindividuals, includingthosewithactiveinflammation, catabolism, orsignificant comorbidities. Moreover, inelderlyindividualsorthosewithfrailtyorsarcopenia, higher proteinintakemaybenecessarytopreventmusclewasting, evenifCKDisadvanced. These nuancedrecommendationsreflectKDIGOscommitmenttoprecisionnutritionbyadapting proteinintakenotonlytokidneyfunctionbutalsotoage, metabolicstate, andphysiologicalneeds. Thisapproachisfurthersupportedbyrecenttrialsandexpertconsensusin nephrologynutrition. Inclinicalpractice, theimplementationoftheserecommendationsrequiresastructured, stepwise approach. First, early identification of patients at risk of malnutrition throughroutinenutritionalscreeningincludingweighttrends, bodycompositionassessment, dietaryrecall, andfunctionalmeasuressuchashandgripstrengthisessential7, 35. Second, individualizeddietaryplansshouldbedevelopedbyrenaldietitiansincollaborationwiththehealthcareteam, tailoringproteinandenergytargetstothepatientsCKD stage, dialysisstatus, comorbidconditions, andlifestylefactors19, 20, 28. Third, patients onloworverylowproteindietsshouldbeconsideredforketo-analogsupplementation, withdosagescarefullycalculatedbasedonbodyweightanddividedacrossmealstooptimizemetaboliceffectsandadherence3034. Fourth, ongoingnutritionalmonitoring throughperiodicbiochemicalmarkerssuchasserumalbumin, prealbumin, nPCR, andinflammatorymarkersalongsideclinicalassessmentsisvitaltoadjustdietaryprescriptionsin responsetochangingmetabolicorclinicalstatus6, 35. Finally, multidisciplinaryeducation andpsychosocialsupportmustbeprovidedtoaddressbarrierstoadherence, including appetitechanges, foodaccessissues, andpatientunderstandingofdietarygoals10, 22. This comprehensive approach enhances the likelihood of achieving a balance between renalprotectionandnutritionaladequacy, therebyimprovingclinicaloutcomesinCKD patients7, 21. (3) SodiumIntake DietarysodiumrestrictionisacriticalcomponentofmanagingCKDduetoitswellestablishedeffectsonbloodpressurecontrol, extracellularfluidvolumeregulation, Proteinuriareduction, andultimatelytheslowingofCKDprogression. Excessivesodiumintake Nutrients2025, 17, 3264 14of26 contributestosalt-sensitivehypertensionandglomerularhyperfiltration, mechanismsthat acceleratenephronlossandincreasecardiovascularriskinthispopulation. The 2024 Kidney Disease: Improving Global Outcomes Clinical Practice Guideline recommends limiting Sodium intake tolessthan2gperday, equivalenttoapproximately5gofsalt, forpatientsacrossCKD stages3to5, includingbothnon-dialysisanddialysispopulations. Thisrecommendation alignswithglobalcardiovascularhealthtargetsandisdesignedtomitigatehypertension andvolumeoverloadwhileallowingindividualizedadjustmentsbasedonclinicalvolume status, serum Sodium concentrations, and patient symptoms, particularly in elderly or volume-sensitive patients. Similarly, the Kidney Disease Outcomes Quality Initiative 2020 guidelines advocate for Sodium restrictionbelow2. 3gperdayforCKDstages3to5, withadditionalcautionindialysis patientsduetoalteredfluidbalanceandtheriskofintradialytichypotension. Peritoneal dialysispatientsmayrequiremoreflexiblesodiumtargetstomaintainadequatenutrition andvolumecontrol1. TheESPEN2020guidelinessuggestasodiumintakerangeof1. 5 to2gperdayinpre-dialysisCKDpatients, emphasizingtheimportanceofavoidingboth excessivesodiumconsumptionandoverlyaggressiverestriction, especiallyamongelderly orfrailindividualswhoareathigherriskofhyponatremia2. Despitetheseclearnumericaltargets, achievingeffectivesodiumrestrictioninclinical practiceextendsbeyondadvisingpatientstoavoidthesaltshaker. Giventhat7080%of sodiumintakeinindustrializednationsderivesfromprocessedfoods, restaurantmeals, andpackagedsnacks, patienteducationmustfocusonidentifyinghiddensodiumsources withincommondietaryitems. Patientsshouldbetrainedtointerpretnutritionlabelscarefully, recognizingtermssuchasSodium, salt, sodiumchloride, andmonosodium glutamate. Avoidanceofhigh-sodiumprocessedfoodsincludingcannedsoups, deli meats, frozen entrees, soy sauce, and certain condimentsis essential to maintaining sodiumintakewithinrecommendedlimitswithoutcompromisingoverallnutrition. A gradual, staged reduction in Sodium intake has been shown to improve patient adherenceandminimizeadverseeffectssuchasreducedqualityoflifeorhypotension. A practical approach involves decreasing added salt by approximately 25% every two weeks, allowing for taste adaptation. Flavor can be preserved through the use of nonsodiumseasoningssuchasherbs(basil, oregano, thyme), spices(blackpepper, paprika), andacidicflavorings(lemonjuice, vinegar). Collaborationwithrenaldietitiansispivotal todevelopingculturallyandregionallyappropriatelow-sodiummealplansandrecipes thatemphasizehomecookingwithfresh, unprocessedingredientsratherthanrelianceon processedorrestaurantfoods. Regularmonitoringofbloodpressure, volumestatus(includingassessmentofedema andweightchanges), andserumsodiumlevelsisessentialtoguideindividualizedsodium targets and prevent complications such as hyponatremia or intradialytic hypotension, especiallyinelderlyorfrailpatients. Amultidisciplinaryteamapproachinvolvingnephrologists, dietitians, nursingstaff, andsocialworkersensuresthatsodiumrestrictionstrategies arepersonalizedtothepatientsCKDstage, dialysismodality, comorbidities, lifestyle, and preferences, therebypromotingsustainablelong-termadherence. (4) PotassiumIntake ThemanagementofdietarypotassiuminCKDhasevolvedfromuniversalpotassium restrictiontowardamorenuanced, individualizedapproachthatbalancespotassiumcontrolwithoveralldietqualityandnutritionalstatus. The2024KDIGOguidelinerecommends againstroutinepotassiumrestrictioninCKDpatientswithoutpersistenthyperkalemia, emphasizingcorrectionofmodifiablenon-dietarycontributorssuchasmetabolicacidosis, constipation, andmedicationsincludingreninangiotensinaldosteronesystem(RAAS) inhibitorsorpotassium-sparingdiureticsbeforedietarychanges. KDIGOadvisesmaintainingpotassiumintakeconsistentwithahealthydietrichinfruits, vegetables, legumes, and Nutrients2025, 17, 3264 15of26 wholegrainsunlesshyperkalemiapersists, asthesefoodsprovidefiber, antioxidants, and alkalinizingeffectsbeneficialforcardiovascularandkidneyhealth. Kidney Disease: Improving Global Outcomes does not prescribe a fixed Potassium intake limit but recommends individualized targets based on serum Potassium levels and chronic kidney disease stage. For example, in CKDstages35withouthyperkalemia, potassiumintakeisgenerallyunrestricted(often 20004000mg/day, consistentwithgeneralpopulationguidelines), whereasinadvanced stagesordialysispatientswithhyperkalemia, selectiverestrictionofhigh-potassiumprocessedfoodsandadditivesisadvised20. TheKDOQINutritionGuidelines(2020)providemorespecificnumericrecommendations, suggestingpotassiumintakeofapproximately20003000mg/dayinnon-Dialysis CKDpatientswithstablepotassiumlevels. Fordialysispatients, intakemaybeadjustedbetween2000and3500mg/daydependingonserumpotassium, dialysismodality, andresidualrenalfunction, balancingriskofhyperkalemiaagainstnutritionaladequacy. Kidney Disease Outcomes Quality Initiative stressesfrequentserumpotassiummonitoringandindividualizeddietarycounseling19. ESPEN guidelines similarly recommend maintaining Potassium intake within 20003000mg/dayforCKDpatientswithouthyperkalemia, allowingliberalizedintake ofpotassium-richplantfoodstopromotenutritionalquality. Incasesofpersistenthyperkalemia, atailoredreductionfocusingonlimitingpotassiumadditivesandprocessedfoods isrecommended24. Clinically, thefirststepisregularmonitoringofserumpotassiumtoguidedietary recommendations. Whendietarypotassiumrestrictioniswarranted, practicalstrategies includepatienteducationonfoodpreparationtechniquesthatreducepotassiumcontent byupto50%, suchaspeeling, cuttingintosmallpieces, soakingforatleast2h, andboiling in a large volume of Water with discard of the cooking liquid. This approach enables patients to continue consuming nutrient-rich vegetables and legumes while managing hyperkalemiarisk. Patientsshouldbecounseledtochooselower-potassiumfruitssuchasapples, berries, andgrapesandlimithigher-potassiumfruitslikebananas, oranges, andavocadoswhen potassiumlevelsareelevated. Developingculturallysensitiveandindividualizedmeal planswiththesupportofrenaldietitiansimprovesadherenceandnutritionalstatus. Patienteducationontiming(typicallywithmeals)andmonitoringforadverseeffects is essential, with laboratory checks every 2 to 4 weeks following therapy initiation or adjustment. (5) PhosphorusIntake PhosphoruscontrolisessentialinCKDmanagementduetoitspivotalroleinCKDmineralandbonedisorder(chronic Kidney disease-mineral and bone disorder), vascularcalcification, andcardiovascularrisk. The 2024KDIGOguidelinesrecommendanindividualizedapproachtodietaryphosphorusrestriction, guidedbyCKDstage, serumphosphatelevels, andriskofCKD-mineral and bone disorder, ratherthan universallimitation. Phosphorusbioavailabilityvariessubstantiallybysource: plant-based phosphorus, mostlyboundtophytates, haslowabsorption(50%), whileanimal-derived phosphorushasmoderatebioavailability(4060%)Incontrast, inorganicphosphateadditivesfoundinprocessedfoodsexhibitnear-completeabsorption(90100%)andsubstantiallyelevateserumphosphate, makingthemkeytargetsfordietaryintervention43. InearlyCKDstages13withnormalphosphatelevels, strictphosphorusrestriction is generally unnecessary. However, in advanced chronic kidney disease stages 45 and Dialysis patients, phosphorusintakeshouldbelimitedtoapproximately8001000mg/daytomitigatehyperphosphatemiaandsecondaryhyperparathyroidism. Kidney Disease Outcomes Quality Initiative(2020)alignswiththese recommendations, endorsing8001000mg/dayfornon-dialysisCKDpatientswithhyperphosphatemia, withadjustmentsfordialysispopulations. ESPENandISRNMguidelines Nutrients2025, 17, 3264 16of26 similarly recommend phosphorus intakes below 1000 magnesium/day in advanced chronic kidney disease and Dialysis, individualizedbyresidualkidneyfunctionandphosphatebinderuse. Clinicalmanagementshouldprioritizepatienteducationtoidentifyandavoidphosphateadditivesfrequentlylabeledasphosphate, phosphoricacid, orpolyphosphate inprocessedmeats, sodas, andbakedgoods. Practicalcookingmethodssuchasovernight soakingandboilingwithdiscardedsoakingwatercanreducephosphorusinplantfoodsby 3050%, enablingcontinuedintakeofnutrient-richlegumesandwholegrains. Balancing phosphorusrestrictionwithadequateproteinintakeiscriticaltopreventprotein-energy wasting; thus, monthlymonitoringofserumphosphateandnutritionalstatusisessential. Phosphatebindersremainacornerstoneforcontrollinghyperphosphatemiawhendiet aloneisinsufficient, withemphasisontakingbinderswithmealsandmonitoringadherence andsideeffects. When integrating chronic Kidney disease-mineral and bone disorder management, it is vital to consider not only serum phosphatebutalsocalciumlevels, parathyroidhormone(parathyroid hormone), andfibroblastgrowthfactor 23(FGF23), asthesebiomarkersinformphosphorustargetsandtreatmentintensity44. Elevated phosphate and parathyroid hormone levels accelerate vascular calcification and bone disease; thus, cliniciansmusttailorphosphorusintakeandbindertherapyaccordinglytominimize these risks. Moreover, dietary phosphorus restriction must be carefully balanced with calcium intake and vitamin D status to optimize bone health and avoid exacerbating secondaryhyperparathyroidism. Recentevidenceunderscorestheimportanceofavoiding excessivecalcium-basedphosphatebindersinpatientswithvascularcalcification, favoring non-calciumbinderswhereappropriate45. Amultidisciplinaryteamapproachinvolvingnephrologists, dietitians, pharmacists, andsocialworkersenhancespatientadherenceandoutcomes. 5.",
    "word_count": 595,
    "char_count": 12307,
    "sentence_count": 70,
    "metadata": {
      "source_file": "e554aa91d426eee7edf579315638edf64d3f.pdf",
      "extraction_date": "2025-12-31T14:48:14.772187",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "chronic kidney disease",
        "CKD",
        "dialysis",
        "kidney function",
        "renal",
        "nephrology"
      ],
      "chunk_index": 4,
      "total_chunks": 11,
      "position": "5/11",
      "content_type": "dietary",
      "content_type_confidence": 14,
      "medical_entities": [
        "chronic kidney disease",
        "sodium",
        "potassium",
        "calcium",
        "phosphate",
        "phosphorus",
        "magnesium",
        "parathyroid hormone",
        "vitamin D",
        "diet"
      ],
      "entity_count": 10
    }
  },
  {
    "chunk_id": 5,
    "text": "Recentevidenceunderscorestheimportanceofavoiding excessivecalcium-basedphosphatebindersinpatientswithvascularcalcification, favoring non-calciumbinderswhereappropriate45. Amultidisciplinaryteamapproachinvolvingnephrologists, dietitians, pharmacists, andsocialworkersenhancespatientadherenceandoutcomes. 5. SpecialConsiderationsinAssessingNutritionalStatusof CKDPatients (1) CognitiveAssessmentinNutritionalStatusEvaluationforCKDPatients Cognitiveimpairmentisincreasinglyrecognizedasacommonandclinicallysignificant comorbidityinpatientswithCKD, particularlyinadvancedstagesandamongdialysis patients. The interplay between cognitive decline and malnutrition creates a complex clinicalscenario, asimpairedcognitioncanleadtopoordietaryadherence, reducedselfcareability, andsubsequentlyworsennutritionalstatus46. Cognitive assessment should be integrated into the comprehensive evaluation of nutritionalstatusinCKDpatientstoidentifythoseatriskformalnutritionduetodecreased abilitytomanagedietaryrestrictionsandnutritionplans. Standardizedscreeningtools suchastheMontrealCognitiveAssessment(MoCA)andMini-MentalStateExamination (MMSE)arecommonlyemployedtodetectmildcognitiveimpairmentanddementiain thispopulation. Earlyidentificationallowsfortailoredinterventions, includingcaregiver involvementandsimplifiednutritionregimens47. SeveralpathophysiologicalmechanismscontributetocognitiveimpairmentinCKD, includinguremictoxinaccumulation, chronicinflammation, anemia, andvasculardisease, allofwhichmayalsoexacerbatemalnutritionandfrailty. Therefore, cognitivedeclineand malnutritionshareoverlappingpathwaysandshouldbeaddressedsimultaneously48. Practicalapproachestointegratecognitiveassessmentintonutritionalmanagementinvolvemultidisciplinarycollaborationamongnephrologists, dietitians, neuropsychologists, andsocialworkers. Forpatientswithdocumentedcognitivedeficits, interventionsmightincludesimplifieddietaryinstructions, oralnutritionalsupplementswitheasyadministration, andenhancedcaregivereducationtoensureadherence49. Nutrients2025, 17, 3264 17of26 Recentguidelinesemphasizethatcognitivescreeningisanessentialcomponentof comprehensiveCKDcare, asaddressingcognitiveimpairmentmayimprovenutritional outcomesandoverallqualityoflife. Futureresearchiswarrantedtoestablishstandardized protocolsforcognitiveandnutritionalassessmentandtodeveloptargetedinterventions thataddressthisdualburden. (2) NutritionalAssessmentandInterventioninFrailCKDPatients Frailty significantly complicates nutritional assessment and management in chronic kidney disease patientsduetoitsassociationwithdecreasedmusclemass, functionalimpairment, and chronicinflammation50. NutritionalevaluationinfrailCKDpatientsshouldinclude objectivemeasuresofmusclefunctionandquantity, suchasHGSwithcutoffsbelow27kg formenand16kgforwomenindicatingreducedmusclestrength, asrecommendedbythe EuropeanSocietyforClinicalNutritionandMetabolism. MusclemassassessmentviaBIA orDXAisessential, withappendicularskeletalmusclemassindex(ASMI)thresholdsof 7. 0kg/m2 formenand5. 5kg/m2 forwomensignalingsarcopenia, whichfrequently coexists with frailty. These functional and morphological assessments are crucial, as traditional markers such as body mass index or serum albumin are often misleading due to fluid overloadandsystemicinflammationprevalentinthispopulation39, 51. Duetofrequentanorexia, earlysatiety, andgastrointestinalsymptomsinfrailCKD patients, multidisciplinary interventions including appetite stimulants, individualized mealplansenrichedwithleucineorbranched-chainaminoacids, andresistanceexercise programsareadvisedtoimproveprotein-energystatusandmusclefunction. Monitoring shouldbeperformedevery13monthswithrepeatassessmentsofmusclestrength, dietaryintake, andbiochemicalmarkerstopromptlyidentifynutritionaldeclineandadjust treatment. Thiscomprehensiveandproactivestrategyisessentialtoreducehospitalization rates, morbidity, andmortalityassociatedwithfrailtyinCKD19, 20, 51(Table2). NutritionalinterventioninfrailCKDpatientsrequiresatailoredapproachthatbalances the increased Protein needs necessary to combat muscle wasting with the risk of acceleratingkidneydiseaseprogression. Energyandproteinintakeshouldbemonitored. Furthermore, chronicinflammationahallmarkoffrailtycanelevateproteincatabolism and reduce appetite, requiring regular monitoring of inflammatory markers such as Creactive Protein (CRP), with levels 5 magnesium/L indicating active inflammation that may necessitateanti-inflammatoryandnutritionalsupportinterventions10, 19, 20. (3) NutritionalAssessmentandInterventioninMalignancyCKDPatients EnergyrequirementsinCKDpatientswithmalignancyaregenerallyincreaseddueto thehypermetabolicstateassociatedwithcancer. ESPENguidelinesrecommendtargeting anenergyintakeof3035kcal/kg/dayinstableCKD, increasingto35kcal/kg/dayor more during active cancer treatment or episodes of inflammation 21. Protein intake must be carefully balanced: while standard chronic kidney disease management often limits Protein to 0. 60. 8 g/kg/day in non-Dialysis stages to reduce Kidney workload, patients with malignancy-relatedPEWrequireahigherproteinprovisionofatleast1. 2g/kg/dayto supportmusclemaintenanceandimmunefunction. Indialysis-dependentpatients, atarget proteinintakeof≥1. 2g/kg/dayisadvised, withclosemonitoringtoavoidexacerbating azotemia19, 21, 52(Table2) Nutritionalinterventionsshouldincorporateearlyandaggressivestrategies, including oralnutritionalsupplementsenrichedwithomega-3fattyacidsandbranched-chainamino acids, which have shown efficacy in attenuating muscle wasting and inflammation in cancer-CKDpopulations53. Inpatientsunabletomeetenergyandproteinneedsorally, enteralnutritionispreferredoverparenteralroutestomaintaingutintegrityandreduce infectionrisk. Furthermore, pharmacologicadjunctssuchasappetitestimulantsorantiNutrients2025, 17, 3264 18of26 inflammatoryagentsmaybeconsidered, althoughtheserequireindividualizedrisk-benefit analysisgiventhealteredpharmacokineticsinCKDandcancer21. Regularnutritionalreassessmentevery46weeksiscrucialinthisgroupduetothe dynamicnatureofmalignancy-associatedmetabolicchangesandtheincreasedriskofrapid deterioration19. Multidisciplinarycollaborationinvolvingnephrologists, oncologists, dietitians, andpalliativecarespecialistsisessentialtooptimizenutritionalstatus, improve qualityoflife, andpotentiallyenhanceclinicaloutcomesinCKDpatientswithmalignancy. (4) NutritionalAssessmentandInterventioninMulti-tablettherapy CKDpatientsundergoingmulti-tablettherapypresentuniquechallengesinnutritional assessment and intervention due to the High risk of drugnutrient interactions, altered appetite, and impaired nutrient. Polypharmacy, often defined as the concurrent use of five or more medications, is prevalent in chronic kidney disease populations, with some patients taking upwardsof1015tabletsdailytomanagecomorbiditiessuchashypertension, Diabetes, andmineralbonedisorders. Thiscomplexitynecessitatesmeticulousnutritionalevaluation andindividualizedinterventionplans. Nutritionalassessmentinthiscontextmustincorporateathoroughmedicationreview toidentifyagentsthatmayadverselyaffectnutritionalstatus. Forexample, phosphate binderscaninterferewiththeabsorptionoffat-solublevitaminsandtraceelements, while protonpumpinhibitors(PPIs)reducegastricacidity, impairingcalciumandvitaminB12 absorption. Appetitesuppressioncausedbymedicationslikebeta-blockersandcertain antidepressantsshouldalsobeevaluatedusingvalidatedtoolssuchastheAppetite, Hunger andSensoryPerception(AHSP)questionnaire, withscoresbelow40indicatingclinically significantanorexiawarrantingintervention24. Intervention strategies should prioritize simplifying medication regimens where feasible, collaborating with pharmacists to minimize pill burden and reduce adverse nutritional impacts. Nutritional supplementation may include High-Protein oral nutritionalsupplementsfortifiedwithmicronutrients, particularlyvitaminD3(cholecalciferol 10002000IU/day)andB-complexvitamins, tocompensateformalabsorptionrisks. Additionally, monitoring and managing gastrointestinal side effects such as nausea and constipationcommonwithmultiplemedicationsarecritical, utilizingprokineticagents orfibersupplementsasappropriatetomaintainadequatenutrientintake. Regularreassessmentevery3monthsisrecommendedtoadjustnutritionalplansinresponsetochangesinmedicationregimensorclinicalstatus. Multidisciplinarycoordination betweennephrologists, dietitians, pharmacists, andprimarycareprovidersisparamountto optimizebothpharmacologicalandnutritionalcare, therebyimprovingpatientoutcomes andqualityoflifeinCKDpatientsoncomplexmulti-tablettherapies. (5) NutritionalInterventionUsingOralNutritionalSupplements OralNutritionalSupplements(ONS)areindicatedinCKDpatientswhodonotachieve adequatenutritionalintakedespitedietarycounseling, particularlythosemeetingoneor moreofthefollowingobjectivecriteria: unintentionalweightlossexceeding5%within 13 months or 10% over 6 months (serum albumin persistently below 3. 8 grams per deciliter), dietaryenergyintakeconsistentlylessthan75%ofrecommendedrequirements, typically 25 kcal/kg/day, and Protein intake below 0. 8 g/kg/day in non-Dialysis or below 1. 2g/kg/dayindialysispatients. Additionally, handgripstrengthfallingbelow27kgin menand16kginwomenorevidenceofmusclemassdepletionbybioelectricalimpedance analysis(e. g. , phaseangle5)supportsONSinitiation. Chronicinflammationindicated byelevatedC-reactiveprotein(5mg/L)furthersubstantiatestheneedforONSdueto increasedcatabolicdemands20, 22, 24, 52(Table3). Nutrients2025, 17, 3264 19of26 Table3. ONSSupplementationanditsoutcomesandmonitoringbyCKDstage. CKDStage/Dialysis RecommendedProtein KeyNutrition Assessment ONSIndication ExpectedOutcomes MonitoringParameters Status Intake(IncludingONS) Composition Interval - Improvedserum - Inadequatedietary - 0. 550.",
    "word_count": 494,
    "char_count": 9789,
    "sentence_count": 59,
    "metadata": {
      "source_file": "e554aa91d426eee7edf579315638edf64d3f.pdf",
      "extraction_date": "2025-12-31T14:48:14.772187",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "chronic kidney disease",
        "CKD",
        "dialysis",
        "kidney function",
        "renal",
        "nephrology"
      ],
      "chunk_index": 5,
      "total_chunks": 11,
      "position": "6/11",
      "content_type": "dietary",
      "content_type_confidence": 9,
      "medical_entities": [
        "chronic kidney disease",
        "phosphate",
        "magnesium",
        "nutritional assessment",
        "malnutrition",
        "dialysis",
        "anemia",
        "monitoring"
      ],
      "entity_count": 8
    }
  },
  {
    "chunk_id": 6,
    "text": "ONSSupplementationanditsoutcomesandmonitoringbyCKDstage. CKDStage/Dialysis RecommendedProtein KeyNutrition Assessment ONSIndication ExpectedOutcomes MonitoringParameters Status Intake(IncludingONS) Composition Interval - Improvedserum - Inadequatedietary - 0. 550. 60g/kg/day - Renal-specific - Serumalbumin, albumin intake(75% Protein formulas prealbumin ( C N potassium o D n3 D i 5 alysis) e ta n r e g r e g t y s) /Protein - s to up m p e l e e t m ta e r n g t e e t d s b w y it O ho N u S t - - 10 2 0 1 0 5 3 g 00 pr potassium o c t a e l in - P lo r s e s ventionofweight - - E B l o e d c y tro w ly ei t g es height (P, potassium) Every13months - Maintenanceof - PresenceofPEW exceeding - LowNa, potassium, Pcontent - Musclestrength musclemass - Increasedserum - Serumalbumin - Persistent albumin - nPCR inadequateintake - Renal-specificONS - ImprovedBMI, lean - 1. 01. 2g/kg/day - Electrolytes(P, potassium) despitecounseling - 300400kcal, bodymass HDpatients - Presenceof proteintotal - 525gprotein - Enhancedmuscle - Fluidstatus Every13months - IncludingONS - Interdialytic malnutritionor - LowP, Kcontent strength weightgain protein-energy wasting - Reduced - Musclefunction hospitalizationrates - SameasHD - Additionallosses - 1. 01. 2g/kg/day - Similarrenal-specific - Betterpreservation Asaboveplusperitoneal PDpatients ofproteinvia includingONS ONSformula ofnutritionalstatus dialysisparameters Every13months dialysisfluid - Musclemass (dialysateproteinlosses) increaseneeds chronic kidney disease, chronickidneydisease; hemodialysis, hemodialysis; potassium, Potassium; sodium, Sodium; ONS, oralnutritionalsupplement; peritoneal dialysis, peritonealdialysis; protein-energy wasting, Protein-energywasting; P, phosphorus. Nutrients2025, 17, 3264 20of26 In Dialysis patients, who require higher Protein intake (1. 21. 5 g/kg/day) to compensate for treatment-related losses, renal-specific ONS with controlled electrolytes Potassium300mg and phosphorus 250 magnesium per servingsuch as Nepro HP or NovasourceRenalarerecommended. Fornon-dialysisCKDstages35patients, proteinintake targetsare0. 60. 8g/kg/day, withenergyneedsaround3035kcal/kg/day; Low-Protein, energy-densesupplementslikeRenilon7. 5aresuitabletomeettheserequirementswhile minimizingnitrogenload. ExpectedbenefitsfromONSincludepreventionorreversalofPEW, demonstratedby weightstabilizationorgain12kgover3months, improvementsinserumalbuminby 0. 20. 4g/dL, enhancedmusclestrength, decreasedhospitalizationratesbyapproximately 20%, andlowermortalityrisk, especiallyindialysispopulations. IntradialyticONSadministrationimprovesadherenceandnutritionalstatuswithoutsuppressingappetite. Thus, ONSarecriticalinmitigatingmalnutrition-relatedmorbidityandmortalityinCKD. 6. CollaborationandPatientEducationinNutritionalManagement ofCKD AddressingmalnutritionstemmingfromnutritionalinsecurityinpatientswithCKD requiresacomprehensive, multifaceted, andmeasurableapproach. Centraltothisendeavor is ensuring patients consistently meet their minimum nutritional requirements, which demandsbothimprovedfoodaccessandsystematicpatienteducation19. ManyCKDpatientsfacefinancialandresourcelimitationsthatrestricttheiraccessto nutrient-dense, Kidney-friendlyfoodssuchaslow-potassiumfruitsandvegetables, whole grains, andaffordable, High-qualityproteinsourceslikeeggsandlegumes. Connecting patientswithfoodassistanceprogramsthatprovidetheseoptionsisimperative. Moreover, educationfocusedonbudget-consciousmealplanningsuchasselectingfrozenorcanned Low-sodiumvegetablesandincorporatingplant-basedproteinsempowerspatientsto makeappropriatedietarychoiceswithintheireconomicmeans. Beyondfoodaccessandeducation, effectivenutritionalmanagementnecessitatesmultidisciplinarycollaborationinvolvingphysicians, registereddietitians, nurses, andsocial workers. Registereddietitianswithexpertiseinrenalnutritionserveasprimaryproviders of personalized dietary counseling tailored to individual patient needs. Nephrologists, nurses, andsocialworkerssupportthisprocessbyreinforcingdietaryadvice, managingcomorbidconditions, andfacilitatingpatientadherence. Inresource-limitedsettings, trained peereducatorsandcommunityhealthworkersmaysupplementprofessionalcaretoextend educationalreachandengagement. Social workers play a pivotal role in mitigating psychosocial barriers by linking patientswithcommunityresources, includingfoodassistanceprograms, transportation, andfinancialsupport. Nursescontributethroughongoingmonitoringandreinforcement of educational messages. This multidisciplinary team collaborates to assess nutritional statususingvalidatedtoolsandtoformulateindividualizedcareplansaddressingnotonly dietary intake but also underlying factors such as inflammation, metabolic imbalances, andpsychosocialchallenges. Regularcommunicationamongteammembersfacilitates timelymodificationsinnutritionalinterventions, therebyenhancingadherenceandclinical outcomes(seeFigure1). Nutrients2025, 17, 3264 21of26 Figure 1. Multidisciplinary team for nutrition intervention. chronic kidney disease, chronic Kidney disease; MIS, malnutrition-inflammationscore; SGA, subjectiveglobalassessment. 7. WhoShouldProvideNutritionalEducation? Nutritionaleducationshouldprimarilybedeliveredbyregistereddietitianswithspecializedexpertiseinrenalnutrition, whocantailordietarycounselingtotheuniqueneeds ofeachpatient. Supportingrolesarefulfilledbynephrologists, nurses, andsocialworkers whoreinforcenutritionaladvice, managecomorbidities, andpromoteadherencetodietary plans. Insettingswithlimitedresources, trainedpeereducatorsandcommunityhealth workerscanexpandthereachofeducationalefforts, ensuringwiderpatientengagement andsupport. 8. HowShouldNutritionalEducationBeDelivered? Effective education must be interactive, patient-centered, and adapted to the individualsliteracylevelandpsychosocialcontext. Combiningverbalcounselingwithclear, accessiblewrittenmaterialsenhancespatientunderstanding. Visualaidssuchasportion controlplates, foodmodels, anddigitalapplicationsarevaluabletoolsforconveyingcomplexdietaryconcepts. Bothone-on-onecounselingandgroupsessionsprovidedistinct benefits: personalizedproblem-solvingversuspeersupportandsharedlearning. Telehealth platformshavebecomeincreasinglyimportant, especiallyduringtheCOVID-19pandemic, allowingflexible, continuouseducationandfollow-up. 9. FrequencyandTimingofNutritionalEducation Educational interventions should begin promptly at chronic kidney disease diagnosis and intensify during critical clinical transitions, including progression to advanced chronic kidney disease stages 45, dialysisinitiation, andpost-transplantperiods. Follow-upsessionsarerecommendedat regularintervals, typicallyevery3to6months, withflexibilitytoincreasefrequencybased on nutritional risk, laboratory data, or hospitalizations. This iterative process requires ongoingreassessmentandadjustmentofeducationstrategiestoaccommodatechangesin clinicalstatus, cognitivefunction, andpsychosocialfactors, therebyoptimizingadherence andimprovingpatientoutcomes. ParticipationinprofessionalworkshopsandconferencessuchastheInternational CongressofRenalNutritionandMetabolism, theISRNMTotalNutritionTherapyprogram, Nutrients2025, 17, 3264 22of26 andESPENcoursesprovideshealthcareprofessionalswithupdatedknowledgeandbest practices, furtherenhancingthequalityofnutritionalcare. Byintegratingevidence-basedstrategieswithcollaborativemultidisciplinaryteamworkandpatient-centerededucation, healthcareproviderscanmoreeffectivelycombat malnutritioncausedbynutritionalinsecurity, ultimatelyimprovingbothqualityoflifeand prognosisforpatientswithCKD. 10. EmergingTechnologiesandFutureDirection Theconceptofprecisionnutritionisincreasinglybeingintroducedinthemanagement of patients with chronic kidney disease. Precision nutrition means an individualized approach in which dietaryinterventionaretailoredaccordingtopatientsgenetic, biologicandenvironmental factors. Itreflectsgenetic, metabolic, andorphysiologicfactorsthataffecthowdifferent patientsrespondtospecificdietaryinterventions. Incontrasttoconventionalnutritional managementapproach, whichtypicallyutilizeaone-size-fits-allmodel, precisionnutrition andpersonalizednutritionutilizeanindividualizedapproach. (e. g. , genetic, microbiome, metabolic). Also, itconsidersfactorssuchaslifestyle, environment, andpatientspreference. Precisionnutritionisevolvingrapidlywithadvancesindatacollection, deepdataanalysis, and modeling with application of artificial intelligence, while personalized nutrition is whatwepracticetodayleveragingavailabledataandguidelinestomeeteachindividualpatientsneeds54. Nutri-genetics, nutrigenomics, microbiomeprofiling, metabolomics, and proteomicscanbeadjustedtoguidedietaryrecommendationsaccordingtoanindividuals uniquecharacteristics55.",
    "word_count": 600,
    "char_count": 8753,
    "sentence_count": 64,
    "metadata": {
      "source_file": "e554aa91d426eee7edf579315638edf64d3f.pdf",
      "extraction_date": "2025-12-31T14:48:14.772187",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "chronic kidney disease",
        "CKD",
        "dialysis",
        "kidney function",
        "renal",
        "nephrology"
      ],
      "chunk_index": 6,
      "total_chunks": 11,
      "position": "7/11",
      "content_type": "dietary",
      "content_type_confidence": 12,
      "medical_entities": [
        "chronic kidney disease",
        "sodium",
        "potassium",
        "phosphorus",
        "magnesium",
        "nutrition",
        "malnutrition",
        "dialysis",
        "hemodialysis",
        "peritoneal dialysis"
      ],
      "entity_count": 10
    }
  },
  {
    "chunk_id": 7,
    "text": "Nutri-genetics, nutrigenomics, microbiomeprofiling, metabolomics, and proteomicscanbeadjustedtoguidedietaryrecommendationsaccordingtoanindividuals uniquecharacteristics55. Therehasbeengrowinginterestinhownutri-genetics, whichstudiestheroleofgenetic polymorphismontherelationshipbetweendietarypatternsandphenotypes, affectsCKD outcomes. Forexample, certainCKDpatientsmaycarrypolymorphismsingenesrelatedto vitaminDmetabolism(suchastheVDRgene), whichcaninfluencetheirvitaminDstatus andresponsetosupplementation. Byidentifyingthesegeneticvariants, clinicianscantailor vitaminDdosingtooptimizebonehealthandreducecardiovascularrisksmoreprecisely thanstandardprotocols. Furthermore, withmicrobiomeprofiling, CKDisassociatedwith gut dysbiosis, which can worsen uremic toxin accumulation and inflammation 56, 57. Microbiomeprofilingidentifiesindividualmicrobialcompositions, enablingpersonalized dietary recommendations to promote beneficial bacteria 58, 59. For example, a chronic kidney disease patientwithlowlevelsofshort-chainfattyacid(SCFA)-producingbacteriamightreceive tailoredprebioticandfiber-richdietstorestoremicrobialbalanceandreducetoxinlevels likeindoxylsulfate53, 60. Afterall, advancingprecisionnutritioninkidneyheathwillrequiremultidisciplinary collaborationandfurtherstudyoftheintegrationofadvancedtechnologiessuchasAIthat canharmonizecomplexdatainordertotailornutritionstrategiesthatwilloptimizethe healthandwell-beingoftheCKDpopulation. 11. Conclusions Malnutrition is highly prevalent among patients with chronic kidney disease and has a detrimental impact on their prognosis; therefore, proactive efforts to improve nutritional status are essential. Nephrologistsshouldpayattentiontoriskofmalnutritionintheirpatientsand toimplementtimelyandproactiveinterventionsaimedatnutritionalimprovement. A multidisciplinary team for management is crucial in the management of malnutritioninCKDpatients. Thestrategytoindividualizedietaryadviceismostimportant. It would be desirable to involve heath care professionals working in nephrology and Dialysis units, educated in screening for malnutrition, and a multidisciplinary team inNutrients2025, 17, 3264 23of26 volvingnephrologists, certifiedregisteredkidneydietitians, andsocialandcommunity healthworkers. The novel tools and emerging technologies to support nutritional assessment will ensuresuccessfulinterventionandpersonalizedmedicine. Developmentofadietquality toolwouldbevaluableandimproveunderstandingofthechangeindietqualityinresponse todietaryinterventions. Large-scale, longitudinalrandomizedtrialsarealsorequiredto establishtheclinicalutilityandcost-effectivenessofusingpropernutritionalassessment toolsanddietarybiomarkers, aswellastheimpactonpatientqualityoflife, burdenofcare, andclinicaldecisionmaking. AuthorContributions: D. potassium. wrotescript. S. Y. collected, analyzedandorganizedthedata. J. W. M. collected, analyzedandorganizedthedata. E. J. potassium. planned, supervised, andgavefinalapprovalfor thescript. Allauthorshavereadandagreedtothepublishedversionofthemanuscript. Funding: Thisresearchreceivednoexternalfunding. ConflictsofInterest: Theauthorsdeclarenoconflictsofinterest. Abbreviations BIA bioelectricalimpedanceanalysis body mass index bodymassindex blood urea nitrogen bloodureanitrogen chronic kidney disease chronickidneydisease DXA dual-energyX-rayabsorptiometry ESPEN Europeansocietyofclinicalnutritionandmetabolism GLIM globalleadershipinitiativeonmalnutrition hemodialysis hemodialysis HGS handgripstrength ISRNM internationalsocietyofrenalnutritionandmetabolism Kidney Disease: Improving Global Outcomes kidneydisease: improvingglobaloutcomes Kidney Disease Outcomes Quality Initiative kidneydiseaseoutcomesqualityinitiative LPDs lowproteindiets MIS malnutrition-inflammationscore MICS malnutrition-inflammationcomplexsyndrome nPCR normalizedproteincatabolicrate ONS oralnutritionalsupplements peritoneal dialysis peritonealdialysis protein-energy wasting proteinenergywasting SGA subjectiveglobalassessment References 1. Carrero, J. J. ; Thomas, F. ; Nagy, potassium. ; Arogundade, F. ; Avesani, C. M. ; Chan, M. ; Chmielewski, M. ; Cordeiro, A. C. ; Espinosa-Cuevas, A. ; Fiaccadori, E. ; etal. GlobalPrevalenceofProtein-EnergyWastinginKidneyDisease: AMeta-analysisofContemporary Observational Studies from the International Society of Renal Nutrition and Metabolism. J. Ren. Nutr. 2018, 28, 380392. CrossRef 2. Woodrow, G. Con: TheroleofdietforpeoplewithadvancedStage5CKD. Nephrol. Dial. Transplant. 2018, 33, 380384. CrossRef PubMed 3. Kalantar-Zadeh, potassium. ; Fouque, D. NutritionalManagementofChronicKidneyDisease. N. Engl. J. Med. 2017, 377, 17651776. CrossRefPubMed 4. Brennan, F. ; Stevenson, J. ; Brown, M. ThePathophysiologyandManagementofTasteChangesinChronicKidneyDisease: A Review. J. Ren. Nutr. 2020, 30, 368379. CrossRefPubMed 5. Chesnaye, N. C. ; Ortiz, A. ; Zoccali, C. ; Stel, V. S. ; Jager, potassium. J. Theimpactofpopulationageingontheburdenofchronickidney disease. Nat. Rev. Nephrol. 2024, 20, 569585. CrossRef Nutrients2025, 17, 3264 24of26 6. Ikizler, T. A. ; Robinson-Cohen, C. ; Ellis, C. ; Headley, S. A. E. ; Tuttle, potassium. ; Wood, R. J. ; Evans, E. E. ; Milch, C. M. ; Moody, potassium. A. ; Germain, M. ; etal. MetabolicEffectsofDietandExerciseinPatientswithModeratetoSevereCKD: ARandomizedClinicalTrial. J. Am. Soc. Nephrol. 2018, 29, 250259. CrossRef 7. Simoes, E. S. A. C. ; Oliveira, E. A. ; Cheung, W. W. ; Mak, R. H. RedoxSignalinginChronicKidneyDisease-AssociatedCachexia. Antioxidants2023, 12, 945. CrossRef 8. Kalantar-Zadeh, potassium. ; Jafar, T. H. ; Nitsch, D. ; Neuen, B. L. ; Perkovic, V. Chronickidneydisease. Lancet2021, 398, 786802. CrossRef 9. Stratton, R. J. ; Hackston, A. ; Longmore, D. ; Dixon, R. ; Price, S. ; Stroud, M. ; King, C. ; Elia, M. Malnutritioninhospitaloutpatients andinpatients: Prevalence, concurrentvalidityandeaseofuseofthemalnutritionuniversalscreeningtool(MUST)foradults. Br. J. Nutr. 2004, 92, 799808. CrossRef 10. Tseng, H. potassium. ; Cheng, Y. J. ; Yu, H. potassium. ; Chou, potassium. T. ; Pang, C. Y. ; Hu, G. C. MalnutritionandFrailtyAreAssociatedwithaHigherRiskof ProlongedHospitalizationandMortalityinHospitalizedOlderAdults. Nutrients2025, 17, 221. CrossRef 11. Mafra, D. ; Borges, N. A. ; Lindholm, B. ; Shiels, P. G. ; Evenepoel, P. ; Stenvinkel, P. Food as medicine: Targeting the uraemic phenotypeinchronickidneydisease. Nat. Rev. Nephrol. 2021, 17, 153171. CrossRef 12. Pereira, C. D. ; Guimaraes, C. ; Ribeiro, V. S. ; Vaz, D. C. ; Martins, M. J. Low-ProteinDiets, Malnutrition, andBoneMetabolismin ChronicKidneyDisease. Nutrients2024, 16, 3098. CrossRefPubMed 13. Hung, potassium.",
    "word_count": 600,
    "char_count": 6678,
    "sentence_count": 96,
    "metadata": {
      "source_file": "e554aa91d426eee7edf579315638edf64d3f.pdf",
      "extraction_date": "2025-12-31T14:48:14.772187",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "chronic kidney disease",
        "CKD",
        "dialysis",
        "kidney function",
        "renal",
        "nephrology"
      ],
      "chunk_index": 7,
      "total_chunks": 11,
      "position": "8/11",
      "content_type": "dietary",
      "content_type_confidence": 9,
      "medical_entities": [
        "chronic kidney disease",
        "urea",
        "potassium",
        "blood urea nitrogen",
        "nutrition",
        "nutritional assessment",
        "malnutrition",
        "dialysis",
        "hemodialysis",
        "peritoneal dialysis"
      ],
      "entity_count": 10
    }
  },
  {
    "chunk_id": 8,
    "text": "Nutrients2024, 16, 3098. CrossRefPubMed 13. Hung, potassium. C. ; Yao, W. C. ; Liu, Y. L. ; Yang, H. J. ; Liao, M. T. ; Chong, potassium. ; Peng, C. H. ; Lu, potassium. C. ThePotentialInfluenceofUremicToxins ontheHomeostasisofBonesandMusclesinChronicKidneyDisease. Biomedicines2023, 11, 2076. CrossRefPubMed 14. Chao, C. T. ; Lin, S. H. UremicToxinsandFrailtyinPatientswithChronicKidneyDisease: AMolecularInsight. Int. J. Mol. Sci. 2021, 22, 6270. CrossRefPubMed 15. Malluche, H. H. ; Monier-Faugere, M. C. ; Blomquist, G. ; Davenport, D. L. Two-yearcorticalandtrabecularbonelossinCKD-5D: Biochemicalandclinicalpredictors. Osteoporos. Int. 2018, 29, 125134. CrossRef 16. Lee, C. L. ; Tsai, S. F. Theimpactofproteindietonbonedensityinpeoplewith/withoutchronickidneydisease: Ananalysisofthe NationalHealthandNutritionExaminationSurveydatabase. Clin. Nutr. 2020, 39, 34973503. CrossRef 17. KidneyDisease: ImprovingGlobalOutcomes(Kidney Disease: Improving Global Outcomes)chronic kidney disease-MBDWorkGroup. KDIGOclinicalpracticeguidelineforthe diagnosis, evaluation, prevention, andtreatmentofChronicKidneyDisease-MineralandBoneDisorder(chronic Kidney disease-mineral and bone disorder). KidneyInt. Suppl. 2009, 113, S1S130. CrossRef 18. Yamada, S. ; Tsuruya, potassium. ; Kitazono, T. ; Nakano, T. Emergingcross-talksbetweenchronickidneydisease-mineralandbonedisorder (chronic Kidney disease-mineral and bone disorder)andmalnutrition-inflammationcomplexsyndrome(MICS)inpatientsreceivingdialysis. Clin. Exp. Nephrol. 2022, 26, 613629. CrossRef 19. Ikizler, T. A. ; Burrowes, J. D. ; Byham-Gray, L. D. ; Campbell, potassium. L. ; Carrero, J. J. ; Chan, W. ; Fouque, D. ; Friedman, A. N. ; Ghaddar, S. ; Goldstein-Fuchs, D. J. ; etal. KDOQIClinicalPracticeGuidelineforNutritioninCKD: 2020Update. Am. J. KidneyDis. 2020, 76, S1S107. CrossRef 20. KidneyDisease: ImprovingGlobalOutcomes(Kidney Disease: Improving Global Outcomes)CKDWorkGroup. KDIGO2024ClinicalPracticeGuidelineforthe EvaluationandManagementofChronicKidneyDisease. KidneyInt. 2024, 105, S117S314. CrossRef 21. Fiaccadori, E. ; Sabatino, A. ; Barazzoni, R. ; Carrero, J. J. ; Cupisti, A. ; DeWaele, E. ; Jonckheer, J. ; Singer, P. ; Cuerda, C. ESPEN guidelineonclinicalnutritioninhospitalizedpatientswithacuteorchronickidneydisease. Clin. Nutr. 2021, 40, 16441668. CrossRefPubMed 22. Ikizler, T. A. ; Cuppari, L. The2020UpdatedKDOQIClinicalPracticeGuidelinesforNutritioninChronicKidneyDisease. Blood Purif. 2021, 50, 667671. CrossRefPubMed 23. Lee, S. W. ; Kim, Y. S. ; Kim, Y. H. ; Chung, W. ; Park, S. potassium. ; Choi, potassium. H. ; Ahn, C. ; Oh, potassium. H. DietaryProteinIntake, ProteinEnergy Wasting, andtheProgressionofChronicKidneyDisease: AnalysisfromtheKNOW-CKDStudy. Nutrients2019, 11, 121. CrossRef PubMed 24. Sabatino, A. ; Fiaccadori, E. ; Barazzoni, R. ; Carrero, J. J. ; Cupisti, A. ; DeWaele, E. ; Jonckheer, J. ; Cuerda, C. ; Bischoff, S. C. ESPEN practicalguidelineonclinicalnutritioninhospitalizedpatientswithacuteorchronickidneydisease. Clin. Nutr. 2024, 43, 22382254. CrossRef 25. Kyle, U. G. ; Bosaeus, I. ; DeLorenzo, A. D. ; Deurenberg, P. ; Elia, M. ; Gomez, J. M. ; Heitmann, B. L. ; Kent-Smith, L. ; Melchior, J. C. ; Pirlich, M. ; etal. BioelectricalimpedanceanalysisPartI: Reviewofprinciplesandmethods. Clin. Nutr. 2004, 23, 12261243. CrossRef 26. Cupisti, A. ; Brunori, G. ; DiIorio, B. R. ; DAlessandro, C. ; Pasticci, F. ; Cosola, C. ; Bellizzi, V. ; Bolasco, P. ; Capitanini, A. ; Fantuzzi, A. L. ; etal. NutritionaltreatmentofadvancedCKD: Twentyconsensusstatements. J. Nephrol. 2018, 31, 457473. CrossRef 27. Detsky, A. S. ; McLaughlin, J. R. ; Baker, J. P. ; Johnston, N. ; Whittaker, S. ; Mendelson, R. A. ; Jeejeebhoy, potassium. N. Whatissubjectiveglobal assessmentofnutritionalstatus? JPENJ. Parenter. Enter. Nutr. 1987, 11, 813. CrossRef 28. Kalantar-Zadeh, potassium. ; Kopple, J. D. Relativecontributionsofnutritionandinflammationtoclinicaloutcomeindialysispatients. Am. J. KidneyDis. 2001, 38, 13431350. CrossRef Nutrients2025, 17, 3264 25of26 29. RupertoLopez, M. ; BarrilCuadrado, G. ; LorenzoSellares, V. Nutritionguidelinesforadvancedchronickidneydisease(ACKD). Nefrologia2008, 28(Suppl. S3), 7986. 30. Lim, H. J. ; Choue, R. NutritionalstatusassessedbythePatient-GeneratedSubjectiveGlobalAssessment(PG-SGA)isassociated withqualitiesofdietandlifeinKoreancerebralinfarctionpatients. Nutrition2010, 26, 766771. CrossRef 31. Fouque, D. ; Kalantar-Zadeh, potassium. ; Kopple, J. ; Cano, N. ; Chauveau, P. ; Cuppari, L. ; Franch, H. ; Guarnieri, G. ; Ikizler, T. A. ; Kaysen, G. ; etal. Aproposednomenclatureanddiagnosticcriteriaforprotein-energywastinginacuteandchronickidneydisease. Kidney Int. 2008, 73, 391398. CrossRef 32. Ishida, Y. ; Maeda, potassium. ; Nonogaki, T. ; Shimizu, A. ; Ueshima, J. ; Nagano, A. ; Kato, R. ; Matsuyama, R. ; Mori, N. Bodymassindexand weightlosspredictmortalityinolderpatientswithchronickidneydisease. Geriatr. Gerontol. Int. 2022, 22, 984985. CrossRef 33.",
    "word_count": 585,
    "char_count": 4997,
    "sentence_count": 114,
    "metadata": {
      "source_file": "e554aa91d426eee7edf579315638edf64d3f.pdf",
      "extraction_date": "2025-12-31T14:48:14.772187",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "chronic kidney disease",
        "CKD",
        "dialysis",
        "kidney function",
        "renal",
        "nephrology"
      ],
      "chunk_index": 8,
      "total_chunks": 11,
      "position": "9/11",
      "content_type": "dietary",
      "content_type_confidence": 5,
      "medical_entities": [
        "chronic kidney disease",
        "potassium"
      ],
      "entity_count": 2
    }
  },
  {
    "chunk_id": 9,
    "text": "Geriatr. Gerontol. Int. 2022, 22, 984985. CrossRef 33. Wang, Z. ; Zhang, J. ; Chan, S. ; Cameron, A. ; Healy, H. G. ; Venuthurupalli, S. potassium. ; Tan, potassium. S. ; Hoy, W. E. BMIanditsassociationwith deathandtheinitiationofrenalreplacementtherapy(RRT)inacohortofpatientswithchronickidneydisease(chronic kidney disease). BMC Nephrol. 2019, 20, 329. CrossRef 34. Kim, B. Y. ; Choi, D. H. ; Jung, C. H. ; Mok, J. O. ; Kim, C. H. Associationsbetweenobesity, weightchangeanddecreasedrenalfunction inKoreantype2diabeticpatients: Alongitudinalfollow-upstudy. BMCEndocr. Disord. 2021, 21, 188. CrossRef 35. Chung, H. F. ; AlMamun, A. ; Huang, M. C. ; Long, potassium. Z. ; Huang, Y. F. ; Shin, S. J. ; Hwang, S. J. ; Hsu, C. C. Obesity, weightchange, and chronickidneydiseaseinpatientswithtype2diabetesmellitus: AlongitudinalstudyinTaiwan. J. Diabetes2017, 9, 983993. CrossRef 36. Chan, S. ; Cameron, A. ; Wang, Z. ; Venuthurupalli, S. potassium. ; Tan, potassium. S. ; Healy, H. G. ; Hoy, W. E. BodymassindexinanAustralian populationwithchronickidneydisease. BMCNephrol. 2018, 19, 209. CrossRefPubMed 37. Kovesdy, C. P. ; Anderson, J. E. ; Kalantar-Zadeh, potassium. Inverseassociationbetweenlipidlevelsandmortalityinmenwithchronic kidneydiseasewhoarenotyetondialysis: Effectsofcasemixandthemalnutrition-inflammation-cachexiasyndrome. J. Am. Soc. Nephrol. 2007, 18, 304311. CrossRefPubMed 38. Hwang, S. H. ; Lee, D. H. ; Min, J. ; Jeon, J. Y. HandgripStrengthasaPredictorofAll-CauseMortalityinPatientsWithChronic KidneyDiseaseUndergoingDialysis: AMeta-AnalysisofProspectiveCohortStudies. J. Ren. Nutr. 2019, 29, 471479. CrossRef PubMed 39. Cruz-Jentoft, A. J. ; Bahat, G. ; Bauer, J. ; Boirie, Y. ; Bruyere, O. ; Cederholm, T. ; Cooper, C. ; Landi, F. ; Rolland, Y. ; Sayer, A. A. ; etal. Sarcopenia: RevisedEuropeanconsensusondefinitionanddiagnosis. AgeAgeing2019, 48, 601. CrossRef 40. Olvera-Soto, M. G. ; Valdez-Ortiz, R. ; LopezAlvarenga, J. C. ; Espinosa-CuevasMde, L. EffectofResistanceExercisesonthe IndicatorsofMuscleReservesandHandgripStrengthinAdultPatientsonHemodialysis. J. Ren. Nutr. 2016, 26, 5360. CrossRef 41. Cederholm, T. ; Jensen, G. L. ; Correia, M. ; Gonzalez, M. C. ; Fukushima, R. ; Higashiguchi, T. ; Baptista, G. ; Barazzoni, R. ; Blaauw, R. ; Coats, A. J. S. ; etal. GLIMcriteriaforthediagnosisofmalnutritionAconsensusreportfromtheglobalclinicalnutrition community. J. CachexiaSarcopeniaMuscle2019, 10, 207217. CrossRef 42. Oliveira, E. A. ; Zheng, R. ; Carter, C. E. ; Mak, R. H. Cachexia/ProteinenergywastingsyndromeinCKD: Causationandtreatment. Semin. Dial. 2019, 32, 493499. CrossRef 43. Carrigan, A. ; Klinger, A. ; Choquette, S. S. ; Luzuriaga-McPherson, A. ; Bell, E. potassium. ; Darnell, B. ; Gutierrez, O. M. Contributionoffood additivestosodiumandphosphoruscontentofdietsrichinprocessedfoods. J. Ren. Nutr. 2014, 24, 1319. CrossRef 44. Bacchetta, J. ; Schmitt, C. P. ; Bakkaloglu, S. A. ; Cleghorn, S. ; Leifheit-Nestler, M. ; Prytula, A. ; Ranchin, B. ; Schon, A. ; Stabouli, S. ; VandeWalle, J. ; etal. DiagnosisandmanagementofmineralandbonedisordersininfantswithCKD: Clinicalpracticepoints fromtheESPNCKD-MBDandDialysisworkinggroupsandthePediatricRenalNutritionTaskforce. Pediatr. Nephrol. 2023, 38, 31633181. CrossRefPubMed 45. Shuto, E. ; Taketani, Y. ; Tanaka, R. ; Harada, N. ; Isshiki, M. ; Sato, M. ; Nashiki, potassium. ; Amo, potassium. ; Yamamoto, H. ; Higashi, Y. ; etal. Dietary phosphorusacutelyimpairsendothelialfunction. J. Am. Soc. Nephrol. 2009, 20, 15041512. CrossRefPubMed 46. Bugnicourt, J. M. ; Godefroy, O. ; Chillon, J. M. ; Choukroun, G. ; Massy, Z. A. Cognitive disorders and dementia in chronic kidney disease: The neglectedkidney-brainaxis. J. Am. Soc. Nephrol. 2013, 24, 353363. CrossRefPubMed 47. Drew, D. A. ; Weiner, D. E. ; Sarnak, M. J. CognitiveImpairmentinCKD: Pathophysiology, Management, andPrevention. Am. J. KidneyDis. 2019, 74, 782790. CrossRef 48. Nasreddine, Z. S. ; Phillips, N. A. ; Bedirian, V. ; Charbonneau, S. ; Whitehead, V. ; Collin, I. ; Cummings, J. L. ; Chertkow, H. The MontrealCognitiveAssessment, MoCA: Abriefscreeningtoolformildcognitiveimpairment. J. Am. Geriatr. Soc. 2005, 53, 695699. CrossRef 49. Bras, A. C. ; Marques, J. ; Fernandes, V. ; Ferreira, A. C. CognitiveDysfunctionScreeninginPeritonealDialysisPatients: ACrossSectionalStudy. IndianJ. Nephrol. 2024, 34, 357362. CrossRef 50. Molinari, P. ; Caldiroli, L. ; Abinti, M. ; Nardelli, L. ; Armelloni, S. ; Cesari, M. ; Castellano, G. ; Vettoretti, S. FrailtyIsAssociatedwith Malnutrition-InflammationSyndromeinOlderCKDPatients. Nutrients2024, 16, 2626. CrossRef 51.",
    "word_count": 594,
    "char_count": 4622,
    "sentence_count": 108,
    "metadata": {
      "source_file": "e554aa91d426eee7edf579315638edf64d3f.pdf",
      "extraction_date": "2025-12-31T14:48:14.772187",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "chronic kidney disease",
        "CKD",
        "dialysis",
        "kidney function",
        "renal",
        "nephrology"
      ],
      "chunk_index": 9,
      "total_chunks": 11,
      "position": "10/11",
      "content_type": "dietary",
      "content_type_confidence": 8,
      "medical_entities": [
        "chronic kidney disease",
        "potassium",
        "malnutrition"
      ],
      "entity_count": 3
    }
  },
  {
    "chunk_id": 10,
    "text": "Nutrients2024, 16, 2626. CrossRef 51. Vettoretti, S. ; Caldiroli, L. ; Armelloni, S. ; Ferrari, C. ; Cesari, M. ; Messa, P. SarcopeniaisAssociatedwithMalnutritionbutNot withSystemicInflammationinOlderPersonswithAdvancedCKD. Nutrients2019, 11, 1378. CrossRefPubMed Nutrients2025, 17, 3264 26of26 52. KidneyDisease: ImprovingGlobalOutcomes(Kidney Disease: Improving Global Outcomes)BloodPressureWorkGroup. KDIGO2021ClinicalPracticeGuidelinefor theManagementofBloodPressureinChronicKidneyDisease. KidneyInt. 2021, 99, S1S87. CrossRefPubMed 53. Lalia, A. Z. ; Dasari, S. ; Robinson, M. M. ; Abid, H. ; Morse, D. M. ; Klaus, potassium. A. ; Lanza, I. R. Influenceofomega-3fattyacidsonskeletal muscleproteinmetabolismandmitochondrialbioenergeticsinolderadults. Aging2017, 9, 10961129. CrossRefPubMed 54. MurilloOrtiz, B. O. ; FuentesPreciado, A. R. ; RamirezEmiliano, J. ; MartinezGarza, S. ; RamosRodriguez, E. ; deAlbaMacias, L. A. RecoveryofBoneandMuscleMassinPatientswithChronicKidneyDiseaseAndIronOverloadonHemodialysisandTaking CombinedSupplementationWithCurcuminandResveratrol. Clin. Interv. Aging2019, 14, 20552062. CrossRef 55. Narasaki, Y. ; Rhee, C. M. ; Li, Z. TheRoleofPrecisionNutritioninKidneyDisease. Clin. J. Am. Soc. Nephrol. 2025, 102215. CrossRef 56. Meijers, B. ; Evenepoel, P. ; Anders, H. J. Intestinalmicrobiomeandfitnessinkidneydisease. Nat. Rev. Nephrol. 2019, 15, 531545. CrossRef 57. Du, J. ; Zhao, X. ; Ding, X. ; Han, Q. ; Duan, Y. ; Ren, Q. ; Wang, H. ; Song, C. ; Wang, X. ; Zhang, D. ; etal. TheRoleoftheGutMicrobiota inComplicationsamongHemodialysisPatients. Microorganisms2024, 12, 1878. CrossRef 58. Lobel, L. ; Cao, Y. G. ; Fenn, potassium. ; Glickman, J. N. ; Garrett, W. S. Dietposttranslationallymodifiesthemousegutmicrobialproteometo modulaterenalfunction. Science2020, 369, 15181524. CrossRef 59. Coutinho-Wolino, potassium. S. ; Melo, M. F. S. ; Mota, J. C. ; Mafra, D. ; Guimaraes, J. T. ; Stockler-Pinto, M. B. Blueberry, cranberry, raspberry, andstrawberryasmodulatorsofthegutmicrobiota: Targetfortreatmentofgutdysbiosisinchronickidneydisease? From currentevidencetofuturepossibilities. Nutr. Rev. 2024, 82, 248261. CrossRef 60. Domazetovic, V. ; Marcucci, G. ; Pierucci, F. ; Bruno, G. ; DiCesareMannelli, L. ; Ghelardini, C. ; Brandi, M. L. ; Iantomasi, T. ; Meacci, E. ; Vincenzini, M. T. BlueberryjuiceprotectsosteocytesandboneprecursorcellsagainstoxidativestresspartlythroughSIRT1. FEBSOpenBio2019, 9, 10821096. CrossRef Disclaimer/PublishersNote: Thestatements, opinionsanddatacontainedinallpublicationsaresolelythoseoftheindividual author(s)andcontributor(s)andnotofMDPIand/ortheeditor(s). MDPIand/ortheeditor(s)disclaimresponsibilityforanyinjuryto peopleorpropertyresultingfromanyideas, methods, instructionsorproductsreferredtointhecontent.",
    "word_count": 288,
    "char_count": 2789,
    "sentence_count": 53,
    "metadata": {
      "source_file": "e554aa91d426eee7edf579315638edf64d3f.pdf",
      "extraction_date": "2025-12-31T14:48:14.772187",
      "document_type": "medical_guideline",
      "language": "en",
      "keywords": [
        "chronic kidney disease",
        "CKD",
        "dialysis",
        "kidney function",
        "renal",
        "nephrology"
      ],
      "chunk_index": 10,
      "total_chunks": 11,
      "position": "11/11",
      "content_type": "dietary",
      "content_type_confidence": 6,
      "medical_entities": [
        "potassium"
      ],
      "entity_count": 1
    }
  }
]